Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in J Nucl Med

Retrieve available abstracts of 501 articles:
HTML format
Text format



Single Articles


    February 2016
  1. NABULSI N, Mercier J, Holden D, Carre S, et al
    Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
    J Nucl Med. 2016 Feb 4. pii: jnumed.115.168179.
    PubMed     Text format     Abstract available


  2. PALYO R, Sinusas A, Liu YH
    High-Sensitivity and High-Resolution SPECT/CT Systems Provide Substantial Dose Reduction without Compromising Quantitative Precision for Assessment of Myocardial Perfusion or Function.
    J Nucl Med. 2016 Feb 4. pii: jnumed.115.164632.
    PubMed     Text format     Abstract available


  3. WARNDERS FJ, Waaijer SJ, Pool M, Lub-de Hooge MN, et al
    Biodistribution and PET Imaging of Labeled Bispecific T Cell Engaging Antibody targeting EpCAM.
    J Nucl Med. 2016 Feb 4. pii: jnumed.115.168153.
    PubMed     Text format     Abstract available


  4. KOESTERS T, Friedman KP, Fenchel M, Zhan Y, et al
    Dixon sequence with superimposed model-based bone compartment provides highly accurate PET/MR attenuation correction of the brain.
    J Nucl Med. 2016 Feb 2. pii: jnumed.115.166967.
    PubMed     Text format     Abstract available


  5. SHEIKHBAHAEI S, Mena E, Marcus C, Wray R, et al
    18F-Fluorodeoxyglucose PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients.
    J Nucl Med. 2016 Feb 2. pii: jnumed.115.165480.
    PubMed     Text format     Abstract available


  6. KENNY L
    The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis.
    J Nucl Med. 2016;57 Suppl 1:89S-95S.
    PubMed     Text format     Abstract available


  7. WAHL RL
    Quo Vadis: PET and Single-Photon Molecular Breast Imaging.
    J Nucl Med. 2016;57 Suppl 1:3S-8S.
    PubMed     Text format    


  8. AVRIL S, Muzic RF Jr, Plecha D, Traughber BJ, et al
    18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.
    J Nucl Med. 2016;57 Suppl 1:34S-9S.
    PubMed     Text format     Abstract available


  9. GROHEUX D, Cochet A, Humbert O, Alberini JL, et al
    18F-FDG PET/CT for Staging and Restaging of Breast Cancer.
    J Nucl Med. 2016;57 Suppl 1:17S-26S.
    PubMed     Text format     Abstract available


    January 2016
  10. LIU D DR, Khong PL, Gao Y, Mahmood U, et al
    Radiation Dosimetry of Whole-Body Dual Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.165944.
    PubMed     Text format     Abstract available


  11. BURGER IA, Casanova R, Steiger S, Husmann L, et al
    FDG-PET/CT of non-small cell lung carcinoma under neo-adjuvant chemotherapy: background based adaptive volume metrics outperform TLG and MTV in predicting histopathological response.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.167684.
    PubMed     Text format     Abstract available


  12. TEUHO J, Johansson J, Liden J, Hansen AE, et al
    Effect of attenuation correction to regional quantification between PET/MR and PET/CT: a multi-centre study using a three-dimensional brain phantom.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.166165.
    PubMed     Text format     Abstract available


  13. BOLLINENI VR, Ytre-Hauge S, Bollineni-Balabay O, Salvesen H, et al
    High diagnostic value of FDG-PET/CT in endometrial cancer: Systematic review and meta-analysis of the literature.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.170597.
    PubMed     Text format     Abstract available


  14. SU Y, Rubin B, McConathy J, Laforest R, et al
    Impact of MR based attenuation correction on neurological PET studies.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.164822.
    PubMed     Text format     Abstract available


  15. SEIBYL J, Catafau AM, Barthel H, Ishii K, et al
    Impact of training method on the robustness of the visual assessment of 18F-florbetaben PET scans: results from a Phase 3 trial.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.161927.
    PubMed     Text format     Abstract available


  16. APOLO AB, Lindenberg L, Shih JH, Mena E, et al
    Prospective Study Evaluating Na18F-Positron Emission Tomography/Computed Tomography (NaF-PET/CT) in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.166512.
    PubMed     Text format     Abstract available


  17. LUO Y, Pan Q, Shao Y, Yu M, et al
    Glucagon-like Peptide-1 Receptor PET/CT with 68Ga-NOTA-exendin-4 for Detecting Localized Insulinoma: a Prospective Cohort Study.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.167445.
    PubMed     Text format     Abstract available


  18. JONASSON M, Wall A, Chiotis K, Saint-Aubert L, et al
    Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.158519.
    PubMed     Text format     Abstract available


  19. O JH, Luber BS, Leal JP, Wang H, et al
    Response to early treatment evaluated with 18F-FDG PET and PERCIST 1.0 predicts survival in patients with Ewing sarcoma family of tumors treated with a monoclonal antibody to the insulin-like growth factor 1 receptor.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.162412.
    PubMed     Text format     Abstract available


  20. VAN ROSSUM PS, Fried DV, Zhang L, Hofstetter WL, et al
    The incremental value of subjective and quantitative assessment of 18F-FDG PET for the prediction of pathologic complete response to preoperative chemoradiotherapy in esophageal cancer.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.163766.
    PubMed     Text format     Abstract available


  21. LUEHMANN HP, Detering L, Fors BP, Pressly ED, et al
    PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.166751.
    PubMed     Text format     Abstract available


  22. VAG T, Gerngross C, Herhaus P, Eiber M, et al
    First Experience on Chemokine Receptor CXCR4 Targeted Positron Emission Tomography (PET) Imaging in Patients with Solid Cancers.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.161034.
    PubMed     Text format     Abstract available


  23. DEPPEN SA, Liu E, Blume JD, Clanton J, et al
    Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging and Treatment Management of Neuroendocrine Tumors.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.163865.
    PubMed     Text format     Abstract available


  24. VILCHE MB, Reyes AL, Vasilskis E, Oliver P, et al
    68Ga-NOTA-UBI 29-41 as a PET tracer for detection of bacterial infection.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.161265.
    PubMed     Text format     Abstract available


  25. JAKOBSEN S, Busk M, Jensen JB, Munk OL, et al
    A PET Tracer For Renal Organic Cation Transporters, 11C-metformin: Radiosynthesis and Preclinical Proof-of-Concept Studies.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.169292.
    PubMed     Text format     Abstract available


  26. SAWICKI LM, Grueneisen J, Buchbender C, Schaarschmidt BM, et al
    Comparative performance of 18F-FDG PET/MRI and 18F-FDG PET/CT regarding detection and characterization of pulmonary lesions in 121 oncologic patients.
    J Nucl Med. 2016 Jan 7. pii: jnumed.115.167486.
    PubMed     Text format     Abstract available


  27. KIM EE
    Nuclear Medicine and PET/CT Cases.
    J Nucl Med. 2016 Jan 7. pii: jnumed.116.172114.
    PubMed     Text format    


  28. SPICK C, Herrmann K, Czernin J
    18F-FDG PET/CT and PET/MRI perform equally well in cancer patients: Evidence from studies in more than 2300 patients.
    J Nucl Med. 2016 Jan 7. pii: jnumed.115.158808.
    PubMed     Text format     Abstract available


  29. JADVAR H
    SNMMI Leadership Update: The Future of Nuclear Medicine.
    J Nucl Med. 2016;57:13N.
    PubMed     Text format    


    December 2015
  30. DECAZES P, Metivier D, Rouquette A, Talbot JN, et al
    A method to improve the semi-quantification of 18F-fluorodeoxyglucose uptake : reliability of the estimated lean body mass using a limited field of acquisition, low dose CT from PET/CT.
    J Nucl Med. 2015 Dec 30. pii: jnumed.115.164913.
    PubMed     Text format     Abstract available


  31. SCHODER H, Zelenetz A, Hamlin P, Gavane S, et al
    Prospective Study of FLT PET for Early Interim Response Assessment in Advanced Stage B-cell Lymphoma.
    J Nucl Med. 2015 Dec 30. pii: jnumed.115.166769.
    PubMed     Text format     Abstract available


  32. GROHEUX D, Biard L, Giacchetti S, Teixeira L, et al
    18FDG-PET/CT for the early evaluation of response to neoadjuvant treatment in triple negative breast cancer: influence of the chemotherapy regimen.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.163907.
    PubMed     Text format     Abstract available


  33. TAGO T, Furumoto S, Okamura N, Harada R, et al
    Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer's Disease.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.166652.
    PubMed     Text format     Abstract available


  34. SCHACHT AC, Sorensen M, Munk OL, Frisch K, et al
    Radiosynthesis of novel N-11C-methyl-taurine conjugated bile acids and biodistribution studies in pigs by PET/CT.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.161711.
    PubMed     Text format     Abstract available


  35. OPREA-LAGER DE, Kramer G, van de Ven P, van den Eertwegh A, et al
    Repeatability of quantitative 18F-fluoromethylcholine PET/CT studies in prostate cancer.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.167692.
    PubMed     Text format     Abstract available


  36. VIVASH LE, O'Brien TJ
    Imaging microglial activation with TSPO PET: Lighting up neurological diseases?
    J Nucl Med. 2015 Dec 23. pii: jnumed.114.141713.
    PubMed     Text format     Abstract available


  37. AN HJ, Seo S, Kang H, Choi H, et al
    MRI-Based Attenuation Correction for PET/MRI Using Multiphase Level-Set Method.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.163550.
    PubMed     Text format     Abstract available


  38. GROGG K, Toole T, Ouyang J, Zhu X, et al
    NEMA and clinical evaluation of a novel brain PET-CT scanner.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.159723.
    PubMed     Text format     Abstract available


  39. KIM SJ, Cho YS, Moon SH, Bae JM, et al
    Primary Tumor FDG Avidity Affects the Performance of FDG PET/CT for Detecting Gastric Cancer Recurrence.
    J Nucl Med. 2015 Dec 17. pii: jnumed.115.163295.
    PubMed     Text format     Abstract available


  40. HOOGENDAM JP, Zweemer RP, Hobbelink MG, van den Bosch MA, et al
    99mTc-nanocolloid SPECT-MRI fusion for the selective assessment of non-enlarged sentinel lymph nodes in patients with early stage cervical cancer.
    J Nucl Med. 2015 Dec 17. pii: jnumed.115.164780.
    PubMed     Text format     Abstract available


  41. DIVINE MR, Katiyar P, Kohlhofer U, Quintanilla-Martinez L, et al
    A Population Based Gaussian Mixture Model Incorporating 18F-FDG-PET and DW-MRI Quantifies Tumor Tissue Classes.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.163972.
    PubMed     Text format     Abstract available


  42. IQBAL R, Kramer GM, Verwer EE, Huisman MC, et al
    Multiparametric analysis of the relationship between tumor hypoxia and perfusion using 18F-FAZA and 15O-H2O PET.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.166579.
    PubMed     Text format     Abstract available


  43. SCHOLTENS AM, Verberne HJ, Budde RP, Lam M, et al
    Additional heparin pre-administration improves cardiac glucose metabolism suppression over low carbohydrate diet alone in 18F-FDG-PET imaging.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.166884.
    PubMed     Text format     Abstract available


  44. MINAMIMOTO R, Hancock S, Schneider B, Chin F, et al
    Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA PET in Patients with Biochemically Recurrent Prostate Cancer.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.168393.
    PubMed     Text format     Abstract available


  45. FUKUSHIMA Y, Kumita SI, Tokita Y, Sato N, et al
    Prognostic value of myocardial perfusion SPECT following intravenous bolus administration of nicorandil in patients with acute ischemic heart failure.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.162420.
    PubMed     Text format     Abstract available


  46. DE SWART J, Chan HS, Goorden MC, Morgenstern A, et al
    Utilizing high-energy gamma photons for high-resolution 213Bi SPECT in mice.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.157685.
    PubMed     Text format     Abstract available


  47. ARULAPPU A, Battle M, Eisenblaetter M, McRobbie G, et al
    c-Met PET Imaging Detects Early Stage Loco-Regional Recurrence of Basal-Like Breast Cancer.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.164384.
    PubMed     Text format     Abstract available


  48. PRIOR JO, Peguret N, Pomoni A, Pappon M, et al
    Reduction of Respiratory Motion during PET/CT by Pulsatile-Flow Ventilation (PFV-PET/CT): A First Clinical Evaluation.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.163386.
    PubMed     Text format     Abstract available


  49. NOTNI J, Steiger K, Hoffmann F, Reich D, et al
    Complementary, Selective PET-Imaging of Integrin Subtypes alpha5beta1 and alphavbeta3 Using Ga-68-Aquibeprin and Ga-68-Avebetrin.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.165720.
    PubMed     Text format     Abstract available


  50. MACDONALD L, Hippe D, Bender L, Cotter E, et al
    Positron emission mammography image interpretation for reduced image count levels.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.165787.
    PubMed     Text format     Abstract available


    November 2015
  51. AARNTZEN E, Hermsen R, Drenth J, Boerman O, et al
    Tc-99m-CXCL8 SPECT to monitor disease activity in inflammatory bowel disease.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.165795.
    PubMed     Text format     Abstract available


  52. NIU G, Chen X
    RGD PET: From Lesion Detection to Therapy Response Monitoring.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.168278.
    PubMed     Text format    


  53. KIST JW, de Keizer B, van der Vlies M, Brouwers AH, et al
    124I PET/CT to predict the outcome of blind 131I treatment in patients with biochemical recurrence of differentiated thyroid cancer; results of a multicenter diagnostic cohort study (THYROPET).
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.168138.
    PubMed     Text format     Abstract available


  54. RUF J, von Wedel F, Furth C, Denecke T, et al
    Significance of a single time point hybrid-protocol for somatostatin receptor SPECT including multiphase CT in the diagnostic work-up of gastroenteoropancreatic neuroendocrine Neoplasms (GEP-NEN).
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.161117.
    PubMed     Text format     Abstract available


  55. MICHL M, Lehner S, Paprottka PM, Ilhan H, et al
    PET response criteria (PERCIST) predict progression-free survival and overall survival after radioembolization for liver metastases from pancreatic cancer.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.165613.
    PubMed     Text format     Abstract available


  56. LOPEZ-RODRIGUEZ V, Galindo-Sarco C, Garcia-Perez FO, Ferro-Flores G, et al
    PET-Based Human Dosimetry of the Dimeric alphavbeta3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.161653.
    PubMed     Text format     Abstract available


  57. PYKA T, Weirich G, Einspieler I, Maurer T, et al
    [68Ga]PSMA-HBED PET for differential diagnosis of suspicious lung lesions in patients with prostate cancer.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.164442.
    PubMed     Text format     Abstract available


  58. WATANABE S, Kato H, Shimosegawa E, Hatazawa J, et al
    Genetic and Environmental Influences on Regional Brain Uptake of 2-deoxy-2-[18F]fluoro-D-glucose: a PET Study in Monozygotic and Dizygotic Twins.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.164004.
    PubMed     Text format     Abstract available


  59. TAHMASIAN M, Shao J, Meng C, Grimmer T, et al
    Based on the network degeneration hypothesis: separating individual patients with different neurodegenerative syndromes in a preliminary hybrid PET/MR study.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.165464.
    PubMed     Text format     Abstract available


  60. GRIMMER T, Wutz C, Alexopoulos P, Drzezga A, et al
    Visual versus fully-automated analyses of FDG- and Amyloid-PET for prediction of dementia due to Alzheimer's disease in mild cognitive impairment.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.163717.
    PubMed     Text format     Abstract available


  61. SHUKURI M, Mawatari A, Ohno M, Suzuki M, et al
    Detection of cyclooxygenase-1 in activated microglia during amyloid plaque progression: PET studies in Alzheimer's disease model mice.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.166116.
    PubMed     Text format     Abstract available


  62. JALLOW N, Christian PE, Sunderland J, Graham MM, et al
    Diagnostic Reference Levels of CT Radiation Dose in Oncology Whole-Body PET/CT.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.160465.
    PubMed     Text format     Abstract available


  63. KIM EE
    Therapeutic Nuclear Medicine.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.169300.
    PubMed     Text format    


  64. JANSSEN I, Chen CC, Taieb D, Patronas NJ, et al
    68Ga-DOTATATE PET/CT in the localization of head and neck paragangliomas compared to other functional imaging modalities and CT/MRI.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.161018.
    PubMed     Text format     Abstract available


  65. SPIELMANN V, Li WB, Zankl M, Oeh U, et al
    Uncertainty Quantification in Internal Dose Calculations for Seven Selected Radiopharmaceuticals.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.160713.
    PubMed     Text format     Abstract available


  66. KANAZAWA M, Ohba H, Harada N, Kakiuchi T, et al
    Evaluation of 6-11C-Methyl-m-tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with beta-11-L-DOPA and 18F-FDOPA in Parkinson's Disease Monkeys.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.161802.
    PubMed     Text format     Abstract available


  67. CHENG SH, Yu D, Tsai HM, Morshed RA, et al
    Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.163006.
    PubMed     Text format     Abstract available


  68. CIVELEK AC
    New Insights: PET imaging to document synergistic therapy effect of the 'old'-ancient recipe, and the 'new'-modern drug in stroke.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.166702.
    PubMed     Text format    


  69. LUO H, England CG, Graves SA, Sun H, et al
    PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-labeled Ramucirumab.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.166462.
    PubMed     Text format     Abstract available


  70. RULLMANN M, Dukart J, Hoffmann KT, Luthardt J, et al
    Partial volume effect correction improves quantitative florbetaben beta-amyloid PET scan analysis.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.161893.
    PubMed     Text format     Abstract available


  71. ZHOU H, Shen G, Zhang W, Cai H, et al
    18F-FDG PET/CT for the diagnosis of residual or recurrent nasopharyngeal carcinoma after radiotherapy: a meta-analysis.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.165407.
    PubMed     Text format     Abstract available


  72. HARADA R, Okamura N, Furumoto S, Furukawa K, et al
    18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer's Disease.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.164848.
    PubMed     Text format     Abstract available


  73. PARKER JA
    From the ABNM: Practice of Nuclear Medicine.
    J Nucl Med. 2015;56:18N.
    PubMed     Text format    


    October 2015
  74. ZANOTTI-FREGONARA P, Xu R, Zoghbi SS, Liow JS, et al
    The positron emission tomographic radioligand 18F-FIMX images and quantifies metabotropic glutamate receptor 1 in proportion to the regional density of its gene transcript in human brain.
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.162461.
    PubMed     Text format     Abstract available


  75. SAWICKI LM, Grueneisen J, Buchbender C, Schaarschmidt BM, et al
    Evaluation of the outcome of lung nodules missed on 18F-FDG PET/MRI compared to 18F-FDG PET/CT in patients with known malignancies.
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.162966.
    PubMed     Text format     Abstract available


  76. RYLOVA SN, Del Pozzo L, Klingeberg C, Tonnesmann R, et al
    Immuno-PET imaging of CD30 positive lymphoma using 89Zr-DFO-AC-10.
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.162735.
    PubMed     Text format     Abstract available


  77. ZHANG H, Liu N, Gao S, Hu X, et al
    Can a Novel 18F-ALF-NOTA-PRGD2 PET/CT Predict the Treatment Sensitivity of Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma?
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.165514.
    PubMed     Text format     Abstract available


  78. SEKINE T, Buck A, Delso G, Ter Voert E, et al
    Evaluation of atlas-based attenuation correction for integrated PET/MR in human brain - application of a head atlas and comparison to true CT-based attenuation correction.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.159228.
    PubMed     Text format     Abstract available


  79. KURLAND BF, Muzi M, Peterson LM, Doot RK, et al
    Multicenter clinical trials using 18F-FDG PET to measure early oncology therapy response: Effects of injection-to-acquisition time variability on required sample size.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.162289.
    PubMed     Text format     Abstract available


  80. BEIJST C, Kist JW, Elschot M, Viergever M, et al
    Quantitative comparison of I-124 PET/CT and I-131 SPECT/CT detectability.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.162750.
    PubMed     Text format     Abstract available


  81. TORRADO-CARVAJAL A, Herraiz JL, Alcain E, Montemayor AS, et al
    Fast Patch-Based Pseudo-CT Synthesis from T1-Weighted MR Images for PET/MR Attenuation Correction in Brain Studies.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.156299.
    PubMed     Text format     Abstract available


  82. ROWE SP, Macura KJ, Ciarallo A, Mena E, et al
    Comparison of PSMA-based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.163782.
    PubMed     Text format     Abstract available


  83. AKLAN B, Oehmigen M, Beiderwellen K, Ruhlmann M, et al
    Impact of Point-Spread Function (PSF) Modeling on PET Image Quality in Integrated PET/MR Hybrid Imaging.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.154757.
    PubMed     Text format     Abstract available


  84. HUELLNER MW, Barbosa FG, Husmann L, Pietsch CM, et al
    TNM staging of NSCLC: Comparison of PET/MR and PET/CT.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.162040.
    PubMed     Text format     Abstract available


  85. SKOURA E, Michopoulou S, Mohmaduvesh M, Panagiotidis E, et al
    The impact of 68Ga-DOTATATE PET/CT imaging on management of patients with neuroendocrine tumours: Experience from a national referral centre in the United Kingdom.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.166017.
    PubMed     Text format     Abstract available


  86. CHAE SY, Choi CM, Shim TS, Park Y, et al
    Exploratory Clinical Investigation of (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate Positron Emission Tomography of Inflammatory and Infectious Lesions.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.164020.
    PubMed     Text format     Abstract available


  87. LJUNGBERG M, Celler A, Konijnenberg MW, Eckerman KF, et al
    MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.159012.
    PubMed     Text format     Abstract available


  88. RUBEAUX M, Joshi N, Dweck MR, Fletcher A, et al
    Motion correction of 18F-sodium fluoride PET for imaging coronary atherosclerotic plaques.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.162990.
    PubMed     Text format     Abstract available


  89. KLENK C, Gawande R, Tran VT, Trinh J, et al
    Progressing towards a cohesive pediatric 18F-FDG PET/MR protocol: Is the administration of Gadolinium-Chelates necessary?
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.161646.
    PubMed     Text format     Abstract available


  90. ZHANG J, Li D, Lang L, Zhu Z, et al
    68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.165316.
    PubMed     Text format     Abstract available


  91. KEYAERTS M, Xavier C, Heemskerk J, Devoogdt N, et al
    Phase I study of 68Ga-HER2-Nanobody for PET/CT assessment of HER2-expression in breast carcinoma.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.162024.
    PubMed     Text format     Abstract available


  92. KRIZSAN AK, Lajtos I, Dahlbom M, Daver F, et al
    Promising future: Comparable Imaging Capability of MRI compatible SiPM and Conventional Photo-sensor Based Preclinical PET Systems.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.157677.
    PubMed     Text format     Abstract available


  93. BAGUNA TORRES J, Andreozzi E, Dunn J, Siddique M, et al
    PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer's Disease.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.162370.
    PubMed     Text format     Abstract available


  94. ZHENG K, Liang N, Zhang J, Lang L, et al
    68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.160648.
    PubMed     Text format     Abstract available


  95. KIM EE
    Molecular Anatomic Imaging: PET/CT, PET/MR and SPECT/CT, third edition.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.167130.
    PubMed     Text format    


  96. GUNGOR H, Saleem A, Babar S, Dina R, et al
    Dose-finding quantitative FDG PET imaging study with the oral pan-AKT inhibitor GSK2141795 in patients with gynecological malignancies.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.156505.
    PubMed     Text format     Abstract available


  97. CZERNIN J
    Reply: Multiple Perspectives on Nuclear Medicine Training.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.166181.
    PubMed     Text format    


  98. OSBORNE JR, Beylergil V, Sammit C, Graham MM, et al
    Letter: Multiple Perspectives on Nuclear Medicine Training.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.165621.
    PubMed     Text format    


  99. WEBER WA, Gatsonis C, Siegel B
    Reply: Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
    J Nucl Med. 2015;56:1636.
    PubMed     Text format    


  100. VAN DEN HOFF J, Hofheinz F
    Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
    J Nucl Med. 2015;56:1635-6.
    PubMed     Text format    


  101. BOHNEN NI
    2015 SNMMI Highlights Lecture: Neurosciences.
    J Nucl Med. 2015;56:13N-20N.
    PubMed     Text format    


  102. COLLAMATI F, Bellini F, Bocci V, De Lucia E, et al
    Time Evolution of DOTATOC Uptake in Neuroendocrine Tumors in View of a Possible Application of Radioguided Surgery with beta- Decay.
    J Nucl Med. 2015;56:1501-6.
    PubMed     Text format     Abstract available


  103. OLIVEIRA BL, Blasi F, Rietz TA, Rotile NJ, et al
    Multimodal Molecular Imaging Reveals High Target Uptake and Specificity of 111In- and 68Ga-Labeled Fibrin-Binding Probes for Thrombus Detection in Rats.
    J Nucl Med. 2015;56:1587-92.
    PubMed     Text format     Abstract available


  104. SELIVANOVA SV, Lavallee E, Senta H, Caouette L, et al
    Radioisotopic Purity of Sodium Pertechnetate 99mTc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications.
    J Nucl Med. 2015;56:1600-8.
    PubMed     Text format     Abstract available


    September 2015
  105. DE LAAT B, Leurquin-Sterk G, Celen S, Bormans G, et al
    Preclinical evaluation and quantification of 18F-FPEB as a radioligand for PET imaging of the metabotropic glutamate receptor 5.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.162636.
    PubMed     Text format     Abstract available


  106. SLOMKA PJ PHD, Rubeaux M PhD, Le Meunier L PhD, Dey D PhD, et al
    Dual-Gated Motion-Frozen Cardiac PET with Flurpiridaz F18.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.164285.
    PubMed     Text format     Abstract available


  107. HARTENBACH M, Weber S, Albert NL, Hartenbach S, et al
    Evaluating treatment response of radioembolization in intermediate stage hepatocellular carcinoma patients using 18Fluoroethylcholine-PET/CT.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.158758.
    PubMed     Text format     Abstract available


  108. AMBROSINI V, Campana D, Polverari G, Peterle C, et al
    Prognostic value of 68Ga-DOTA-NOC PET/CT SUVmax in patients with neuroendocrine tumours of the pancreas.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.162719.
    PubMed     Text format     Abstract available


  109. MINAMIMOTO R, Loening A, Jamali M, Barkhodari A, et al
    Prospective Comparison of 99mTc MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT and Whole-Body MRI in Patients with Breast and Prostate Cancers.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.162610.
    PubMed     Text format     Abstract available


  110. INCERTI E, Fodor A, Mapelli P, Fiorino C, et al
    Radiation treatment of lymph node recurrence from prostate cancer: is 11C-choline PET/CT predictive of survival outcomes?
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.163741.
    PubMed     Text format     Abstract available


  111. ALESSIO AM, Farrell MB, Fahey FH
    Role of Reference Levels in Nuclear Medicine: A Report of the SNMMI Dose Optimization Task Force.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.160861.
    PubMed     Text format    


  112. SHARMA R, Kallur K, Ryu J, Parameswaran R, et al
    Multi-Centre Reproducibility of 18F-Fluciclatide PET Imaging in Subjects with Solid Tumors.
    J Nucl Med. 2015 Sep 17. pii: jnumed.115.158253.
    PubMed     Text format     Abstract available


  113. PARKER CA, Rabiner EI, Gunn R, Searle G, et al
    Human kinetic modelling of the 5-HT6 PET radioligand, 11C-GSK215083, and its utility for determining occupancy at both 5HT6 and 5HT2A receptors by SB742457 as a potential therapeutic mechanism of action in Alzheimer's disease.
    J Nucl Med. 2015 Sep 17. pii: jnumed.115.162743.
    PubMed     Text format     Abstract available


  114. VAN DER VOS CS, Grootjans W, Osborne DR, Meeuwis AP, et al
    Improving the spatial alignment in PET/CT using amplitude-based respiratory gated PET and respiratory triggered CT.
    J Nucl Med. 2015 Sep 17. pii: jnumed.115.163055.
    PubMed     Text format     Abstract available


  115. NIELSEN CH, Erlandsson M, Jeppesen TE, Jensen MM, et al
    Quantitative PET Imaging of Tissue Factor Expression Using 18F-labled Active Site Inhibited Factor VII.
    J Nucl Med. 2015 Sep 17. pii: jnumed.115.154849.
    PubMed     Text format     Abstract available


  116. UMEDA Y, Demura Y, Morikawa M, Anzai M, et al
    Prognostic value of dual-time-point [18F]-2-fluoro-2-deoxyglucose PET for idiopathic pulmonary fibrosis.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.163360.
    PubMed     Text format     Abstract available


  117. HOSOKAWA C, Ishii K, Kimura Y, Hyodo T, et al
    Performance of 11C-PiB PET binding potential images in the equivocal static images in the detection of amyloid deposits.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.156414.
    PubMed     Text format     Abstract available


  118. BLANCHET E, Taieb D, Millo C, Martucci V, et al
    18F-FLT PET/CT in the evaluation of pheochromocytomas and paragangliomas: A pilot study.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.159061.
    PubMed     Text format     Abstract available


  119. KANZAKI Y, Yamauchi Y, Morita H, Hayashi M, et al
    Presence of Post-systolic Shortening Increases the Likelihood of Coronary Artery Disease: A Rest ECG-gated Myocardial Perfusion SPECT Study.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.153791.
    PubMed     Text format     Abstract available


  120. ZHANG H, Song F, Xu C, Liu H, et al
    Spatiotemporal PET imaging of dynamic metabolic changes after combined therapeutic approach of induced pluripotent stem cells (iPSCs), neuronal stem cells (NSCs) and Chinese patent medicine in a rat model of cerebral ischemic-reperfusion injury.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.163170.
    PubMed     Text format     Abstract available


  121. KOSTAKOGLU L, Duan F, Idowu MO, Jolles PR, et al
    A Phase II Study of [(18)F]-3'Deoxy-3'-Fluorothymidine Positron Emission Tomography (FLT-PET) in The Asessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results From ACRIN 6688.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.160663.
    PubMed     Text format     Abstract available


  122. GUTTE H, Hansen AE, Larsen M, Rahbek S, et al
    Simultaneous hyperpolarized 13C-pyruvate MRI and 18F-FDG-PET (hyperPET) in 10 canine cancer patients.
    J Nucl Med. 2015 Sep 3. pii: jnumed.115.156364.
    PubMed     Text format     Abstract available


  123. JOSHI AD, Pontecorvo MJ, Skovronsky DM, Mintun MA, et al
    A semi-automated method for quantification of florbetapir F 18 PET images.
    J Nucl Med. 2015 Sep 3. pii: jnumed.114.153494.
    PubMed     Text format     Abstract available


  124. BEN BOUALLEGUE F, Roubille F, Lattuca B, Cung TT, et al
    SPECT Myocardial Perfusion Reserve in Patients with Multivessel Coronary Disease: Correlation with Angiographic Findings and Invasive Fractional Flow Reserve Measurements.
    J Nucl Med. 2015 Sep 3. pii: jnumed.114.143164.
    PubMed     Text format     Abstract available


  125. LE ROUX PY, Siva S, Steinfort DP, Callahan J, et al
    Correlation of 68Gallium ventilation-perfusion PET/CT with pulmonary function test indices for assessing lung function.
    J Nucl Med. 2015 Sep 3. pii: jnumed.115.162586.
    PubMed     Text format     Abstract available


  126. GORDON L, Metter D, Elman S
    Women in Nuclear Medicine.
    J Nucl Med. 2015;56:20N.
    PubMed     Text format    


  127. SEGALL G
    Nuclear Medicine, Social Media, and Two Degrees of Separation.
    J Nucl Med. 2015;56:19N.
    PubMed     Text format    


  128. FREY KA
    Reply: Alzheimer Disease: Approaches to Early Diagnosis and High-Accuracy Imaging.
    J Nucl Med. 2015;56:1467.
    PubMed     Text format    


  129. MACHULLA HJ
    Alzheimer Disease: Approaches to Early Diagnosis and High-Accuracy Imaging.
    J Nucl Med. 2015;56:1466-7.
    PubMed     Text format    


  130. DILSIZIAN V
    2015 SNMMI Highlights Lecture: Cardiovascular Nuclear and Molecular Imaging.
    J Nucl Med. 2015;56:13N-9N.
    PubMed     Text format    


  131. KING MT, Carpenter CM, Sun C, Ma X, et al
    beta-Radioluminescence Imaging: A Comparative Evaluation with Cerenkov Luminescence Imaging.
    J Nucl Med. 2015;56:1458-64.
    PubMed     Text format     Abstract available


  132. ZIMMERMAN BE, Bergeron DE, Cessna JT
    Impact of Recent Change in the National Institute of Standards and Technology Standard for 18F on the Relative Response of 68Ge-Based Mock Syringe Dose Calibrator Standards.
    J Nucl Med. 2015;56:1453-7.
    PubMed     Text format     Abstract available


  133. VAN DUIJNHOVEN SM, Rossin R, van den Bosch SM, Wheatcroft MP, et al
    Diabody Pretargeting with Click Chemistry In Vivo.
    J Nucl Med. 2015;56:1422-8.
    PubMed     Text format     Abstract available


  134. MAURER AH
    Gastrointestinal Motility, Part 2: Small-Bowel and Colon Transit.
    J Nucl Med. 2015;56:1395-400.
    PubMed     Text format     Abstract available


  135. KEIDING S
    How Should Lumped Constant Be Estimated for Hepatic 18F-FDG Glucose in Humans?
    J Nucl Med. 2015;56:1302-3.
    PubMed     Text format    


  136. MACHULLA HJ
    Imaging of Apoptosis: The Need to Distinguish Tracer Uptake Rate from Regional Contribution of Blood Flow.
    J Nucl Med. 2015;56:1300-1.
    PubMed     Text format    


    August 2015
  137. JACOBSON O, Weiss I, Wang L, Wang Z, et al
    18F-labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.160960.
    PubMed     Text format     Abstract available


  138. RENDON DA, Kotedia K, Afshar SF, Punia JN, et al
    Mapping radiation injury and recovery in bone marrow using 18F-FLT PET/CT and USPIO-MR imaging in a rat model.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.158121.
    PubMed     Text format     Abstract available


  139. GEWIRTZ H
    SPECT MPI: Post stress, end systolic images and the ongoing effort to improve diagnostic accuracy.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.164111.
    PubMed     Text format    


  140. BURT T, Rouse D, Lee K, Wu H, et al
    Intra-Arterial Microdosing (IAM): A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.160986.
    PubMed     Text format     Abstract available


  141. CHOI H, Lee DS
    PET and SPECT of Neurobiological Systems.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.164616.
    PubMed     Text format    


  142. FINK J, Muzi M, Peck M, Krohn KA, et al
    Multi-modality Brain Tumor Imaging - MRI, PET, and PET/MRI.
    J Nucl Med. 2015 Aug 20. pii: jnumed.113.131516.
    PubMed     Text format     Abstract available


  143. CHOI H, Lee DS
    PET and SPECT in Psychiatry.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.164608.
    PubMed     Text format    


  144. IAGARU AH
    18F NaF PET in the Assessment of Malignant Bone Disease.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.162784.
    PubMed     Text format    


  145. AFSHAR-OROMIEH A, Hetzheim H, Kratochwil C, Benesova M, et al
    The novel theranostic PSMA-ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry and first evaluation of tumor lesions.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.161299.
    PubMed     Text format     Abstract available


  146. BUVAT I, Orhlac F, Soussan M
    Tumor texture analysis in PET: where do we stand?
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.163469.
    PubMed     Text format    


  147. PARSONS M, Goldman D, Dashevsky B, Riedl CC, et al
    Value of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Breast Cancer (ILC) as Compared with Invasive Ductal Breast Cancer (IDC).
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.161455.
    PubMed     Text format     Abstract available


  148. FRANZ D, Karampinos DC, Rummeny EJ, Souvatzoglou M, et al
    Discrimination between brown and white adipose tissue using a two-point Dixon water-fat separation method in simultaneous PET/MRI.
    J Nucl Med. 2015 Aug 13. pii: jnumed.115.160770.
    PubMed     Text format     Abstract available


  149. KITKUNGVAN D MD, Vejpongsa P Md, Korrane K Md, Sdringola S Md, et al
    Clinical Utility of Enhanced Relative Activity Recovery on Systolic Myocardial Perfusion SPECT - Lessons from PET.
    J Nucl Med. 2015 Aug 13. pii: jnumed.115.153759.
    PubMed     Text format     Abstract available


  150. LEE DS
    Introduction to book series review: 'PET and SPECT in Neurology, PET and SPECT in Psychiatry, and PET and SPECT of Neurobiological Systems'.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.164582.
    PubMed     Text format    


  151. KIM YK, Lee DS
    PET and SPECT in Neurology.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.164590.
    PubMed     Text format    


  152. BAUMAN A, Valverde IE, Fischer CA, Vomstein S, et al
    Development of Gallium-68 and Zirconium-89 Labelled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.159186.
    PubMed     Text format     Abstract available


  153. MAIER FC, Keller MD, Bukala D, Bender B, et al
    Quantification of beta-amyloidosis and rCBF with dedicated PET, 7 T-MR imaging and high-resolution microscopic MR imaging at 16.4 T in APP23 mice.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.159350.
    PubMed     Text format     Abstract available


  154. ZHANG J, Lang L, Li F, Zhu Z, et al
    Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.159640.
    PubMed     Text format     Abstract available


  155. TASWELL C, Villemagne VL, Yates P, Shimada H, et al
    FDG-PET improves diagnosis in patients presenting with focal onset dementias.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.161067.
    PubMed     Text format     Abstract available


  156. LEE JW, Jo K, Cho A, Noh SH, et al
    Relationship between 18F-FDG uptake on PET and recurrence patterns after curative surgical resection in patients with advanced gastric cancer.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.160580.
    PubMed     Text format     Abstract available



  157. SNMMI 2015 Image of the Year.
    J Nucl Med. 2015;56:9N.
    PubMed     Text format    


  158. ZUBAL G
    From the Exhibitors' Hall: SNMMI Annual Meeting 2015.
    J Nucl Med. 2015;56:16N-19N.
    PubMed     Text format    


  159. HU K, Wang H, Tang G, Huang T, et al
    In Vivo Cancer Dual-Targeting and Dual-Modality Imaging with Functionalized Quantum Dots.
    J Nucl Med. 2015;56:1278-84.
    PubMed     Text format     Abstract available


  160. MUZI M, Peterson LM, O'Sullivan JN, Fink JR, et al
    18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
    J Nucl Med. 2015;56:1223-8.
    PubMed     Text format     Abstract available


  161. BUTOF R, Hofheinz F, Zophel K, Stadelmann T, et al
    Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
    J Nucl Med. 2015;56:1150-6.
    PubMed     Text format     Abstract available


  162. WEINEISEN M, Schottelius M, Simecek J, Baum RP, et al
    68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
    J Nucl Med. 2015;56:1169-76.
    PubMed     Text format     Abstract available


  163. MAURER AH
    Gastrointestinal Motility, Part 1: Esophageal Transit and Gastric Emptying.
    J Nucl Med. 2015;56:1229-38.
    PubMed     Text format     Abstract available


  164. NERI D
    Imaging T Cells In Vivo.
    J Nucl Med. 2015;56:1135-6.
    PubMed     Text format    


  165. TAVARE R, McCracken MN, Zettlitz KA, Salazar FB, et al
    Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.
    J Nucl Med. 2015;56:1258-64.
    PubMed     Text format     Abstract available


    July 2015
  166. JIMENEZ-HEFFERNAN A, Ellman A, Sado HN, Huic D, et al
    Results of a prospective International Atomic Energy Ahency (IAEA) sentinel node trial on the value of SPECT/CT over planar imaging in various malignancies.
    J Nucl Med. 2015 Jul 30. pii: jnumed.114.153643.
    PubMed     Text format     Abstract available


  167. BRUNKEN RC
    Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.161661.
    PubMed     Text format    


  168. YAN J, Lim JC, Loi HY, Khor LK, et al
    Impact of image reconstruction settings on Texture Features in 18F-FDG PET.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.156927.
    PubMed     Text format     Abstract available


  169. HALLE B, Thisgaard H, Hvidsten S, Dam JH, et al
    Estimation of Tumor Volumes by [11C]MeAIB and [18F]FDG PET in an Orthotopic Glioblastoma Rat Model.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.162511.
    PubMed     Text format     Abstract available


  170. PAEZ D, Orellana P, Gutierrez C, Ramirez R, et al
    Current Status of Nuclear Medicine Practice in Latin America and the Caribbean.
    J Nucl Med. 2015 Jul 30. pii: jnumed.114.148932.
    PubMed     Text format     Abstract available


  171. GHEYSENS O, Postnov A, Deroose CM, Vandermeulen C, et al
    Quantification, Variability and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Lean Healthy Humans using 18F-FDG-PET/CT.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.159715.
    PubMed     Text format     Abstract available


  172. HELLWIG S, Frings L, Amtage F, Buchert R, et al
    18F-FDG PET is an early predictor of overall survival in suspected atypical parkinsonism.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.159822.
    PubMed     Text format     Abstract available


  173. WAWRZYNIAK AJ, Dilsizian V, Krantz DS, Harris KM, et al
    High Concordance Between Mental Stress-Induced and Adenosine-Induced Myocardial Ischemia Assessed Using SPECT in Heart Failure Patients: Hemodynamic and Biomarker Correlates.
    J Nucl Med. 2015 Jul 23. pii: jnumed.115.157990.
    PubMed     Text format     Abstract available


  174. LAU J, Liu Z, Lin KS, Pan J, et al
    Trimeric radiofluorinated sulfonamide derivatives to achieve in vivo selectivity for carbonic anhydrase IX-targeted PET imaging.
    J Nucl Med. 2015 Jul 23. pii: jnumed.114.153288.
    PubMed     Text format     Abstract available


  175. AYRES KL, Spottswood SE, Delbeke D, Price RR, et al
    Dose Optimization in Pediatric Bone Scintigraphy: Validation of the 2010 North American Consensus Guidelines.
    J Nucl Med. 2015 Jul 23. pii: jnumed.115.156141.
    PubMed     Text format     Abstract available


  176. SHURYAK I, Dadachova E
    New Approaches for Modeling Radiopharmaceutical Pharmacokinetics Using Continuous Distributions of Rates.
    J Nucl Med. 2015 Jul 23. pii: jnumed.115.160515.
    PubMed     Text format     Abstract available


  177. JENSEN P, Feng L, Law I, Svarer C, et al
    TSPO imaging in glioblastoma multiforme: A direct comparison between 123ICLINDE-SPECT, 18F-FET PET and gadolinium-enhanced MRI.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.158998.
    PubMed     Text format     Abstract available


  178. GRECCHI E, O' Doherty J, Veronese M, Tsoumpas C, et al
    Multimodal Partial Volume Correction - Application to 18F-Fluoride PET/CT bone metastases studies.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.160598.
    PubMed     Text format     Abstract available


  179. WERNER RA, Rischpler C, Onthank D, Lapa C, et al
    Retention Kinetics of the 18F-labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-HED and 123I-MIBG.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.158493.
    PubMed     Text format     Abstract available


  180. KIESS A, Minn I, Chen Y, Hobbs RF, et al
    Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.155929.
    PubMed     Text format     Abstract available


  181. KIMURA Y, Ichise M, Ito H, Shimada H, et al
    PET Quantification of Tau Pathology in Human Brain with 11C-PBB3.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.160127.
    PubMed     Text format     Abstract available


  182. PAN Q, Li J, Li F, Zhou D, et al
    Characterizing POEMS syndrome with 18F-Fludeoxyglucose positron emission tomography/computed tomography.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.160507.
    PubMed     Text format     Abstract available


  183. BYRNE K, Siva S, Chait L, Callahan J, et al
    15-year Experience of 18F-FDG PET Imaging in Response Assessment and Re-staging after Definitive Treatment of Merkel Cell Carcinoma.
    J Nucl Med. 2015 Jul 9. pii: jnumed.115.158261.
    PubMed     Text format     Abstract available


  184. TRAGARDH M, Moller N, Sorensen M
    Methodological Considerations when Performing Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
    J Nucl Med. 2015 Jul 9. pii: jnumed.115.154211.
    PubMed     Text format     Abstract available


  185. NGUYEN NC, Vercher-Conejero JL, Sattar A, Miller M, et al
    Image quality and diagnostic performance of a digital PET prototype in patients with oncologic diseases: Initial experience and comparison with analog PET.
    J Nucl Med. 2015 Jul 9. pii: jnumed.114.148338.
    PubMed     Text format     Abstract available


  186. CHAMPION L, Lerebours F, Alberini JL, Fourme E, et al
    18F-FDG PET/CT to predict response to neoadjuvant chemotherapy and prognosis in inflammatory breast cancer.
    J Nucl Med. 2015 Jul 9. pii: jnumed.115.158287.
    PubMed     Text format     Abstract available


  187. TEOH EJ, McGowan DR, Macpherson RE, Bradley KM, et al
    Phantom and clinical evaluation of the Bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET/CT system.
    J Nucl Med. 2015 Jul 9. pii: jnumed.115.159301.
    PubMed     Text format     Abstract available


  188. BRODOV Y, Gransar H, Dey D, Shalev A, et al
    Combined Quantitative Assessment of Myocardial Perfusion and Coronary Artery Calcium Score by Hybrid 82Rb PET/CT Improves Detection of Coronary Artery Disease.
    J Nucl Med. 2015 Jul 9. pii: jnumed.114.153429.
    PubMed     Text format     Abstract available


  189. MANSOR MS, Boellaard R, Froklage FE, Bakker ED, et al
    Quantification of dynamic 11C-Phenytoin PET studies.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.158055.
    PubMed     Text format     Abstract available


  190. DEN HOLLANDER MW, Bensch F, Glaudemans AW, Oude Munnink TH, et al
    TGF-beta antibody uptake in recurrent high grade glioma imaged with 89Zr-fresolimumab PET.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.154401.
    PubMed     Text format     Abstract available


  191. ROHREN EM, Etchebehere E, Araujo J, Hobbs BP, et al
    DETERMINATION OF SKELETAL TUMOR BURDEN ON 18F-FLUORIDE PET/CT.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.156026.
    PubMed     Text format     Abstract available


  192. SODERLUND TA, Chaal J, Tjio G, Totman JJ, et al
    Beyond 18F-FDG: characterization of PET/CT and PET/MR scanners for a comprehensive set of positron emitters of growing application - 18F, 11C, 89Zr, 124I, 68Ga and 90Y.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.156711.
    PubMed     Text format     Abstract available


  193. KAWADA K, Toda K, Nakamoto Y, Iwamoto M, et al
    Relationship between FDG-PET/CT scans and KRAS Mutations in Metastatic Colorectal Cancer.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.160614.
    PubMed     Text format     Abstract available


  194. CARBONELL F, Zijdenbos AP, Charil A, Grand'Maison M, et al
    Optimal Target Region for Subject Classification based on Amyloid PET Images.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.158774.
    PubMed     Text format     Abstract available


  195. MOROZ MA, Zhang H, Lee J, Moroz E, et al
    Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes.
    J Nucl Med. 2015;56:1055-60.
    PubMed     Text format     Abstract available


  196. LAVISSE S, Garcia-Lorenzo D, Peyronneau MA, Bodini B, et al
    Optimized Quantification of Translocator Protein Radioligand (1)(8)F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
    J Nucl Med. 2015;56:1048-54.
    PubMed     Text format     Abstract available


  197. STRAUSS HW, Narula J, Nakahara T
    Finding Calcium in Noncalcified Lesions: (1)(8)F-Fluoride Offers Insights into Atheroma Evolution.
    J Nucl Med. 2015;56:974-5.
    PubMed     Text format    


  198. FAHEY F, Zukotynski K, Jadvar H, Capala J, et al
    Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy.
    J Nucl Med. 2015;56:1119-29.
    PubMed     Text format    


  199. MENDLER CT, Gehring T, Wester HJ, Schwaiger M, et al
    (8)(9)Zr-Labeled Versus (1)(2)(4)I-Labeled alphaHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo.
    J Nucl Med. 2015;56:1112-8.
    PubMed     Text format     Abstract available


  200. SOJKOVA J, Goh J, Bilgel M, Landman B, et al
    Voxelwise Relationships Between Distribution Volume Ratio and Cerebral Blood Flow: Implications for Analysis of beta-Amyloid Images.
    J Nucl Med. 2015;56:1042-7.
    PubMed     Text format     Abstract available


  201. BRAAT AJ, Smits ML, Braat MN, van den Hoven AF, et al
    (9)(0)Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments.
    J Nucl Med. 2015;56:1079-87.
    PubMed     Text format     Abstract available


  202. JOUTSA J, Johansson J, Seppanen M, Noponen T, et al
    Dorsal-to-Ventral Shift in Midbrain Dopaminergic Projections and Increased Thalamic/Raphe Serotonergic Function in Early Parkinson Disease.
    J Nucl Med. 2015;56:1036-41.
    PubMed     Text format     Abstract available


  203. LE ROUX PY, Pelletier-Galarneau M, de Laroche R, Hofman MS, et al
    Pulmonary scintigraphy for the diagnosis of acute pulmonary embolism: a survey of current practices in Australia, Canada and France.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.157743.
    PubMed     Text format     Abstract available


    June 2015
  204. PENG F, Muzik O, Gatson J, Kernie S, et al
    Detection of Increased 64Cu uptake in Traumatic Brain Injury with 64CuCl2-PET/CT.
    J Nucl Med. 2015 Jun 25. pii: jnumed.115.154575.
    PubMed     Text format     Abstract available


  205. MORIGI JJ, Stricker P, Van Leeuwen P, Tang R, et al
    Prospective Comparison of the detection rate of18F-Fluoromethylcholine and 68Ga-PSMA-HBED PET/CT in men with prostate cancer with rising PSA post curative treatment, being considered for targeted therapy.
    J Nucl Med. 2015 Jun 25. pii: jnumed.115.160382.
    PubMed     Text format     Abstract available


  206. PEREZ-MEDINA C, Tang J, Abdel-Atti D, Hogstad B, et al
    PET Imaging of Tumor-Associated Macrophages with 89Zr-labeled HDL Nanoparticles.
    J Nucl Med. 2015 Jun 25. pii: jnumed.115.158956.
    PubMed     Text format     Abstract available


  207. ULANER GA, Riedl C
    Reply: Breast cancer staging: to which women 18FDG-PET/CT should be offered?
    J Nucl Med. 2015 Jun 25. pii: jnumed.115.161042.
    PubMed     Text format    


  208. KINAHAN PE, Mankoff D, Linden H
    The value of establishing the quantitative accuracy of PET/CT imaging.
    J Nucl Med. 2015 Jun 18. pii: jnumed.115.159178.
    PubMed     Text format    


  209. GATES VL, Singh N, Lewandowski R, Spies SM, et al
    INTRA-ARTERIAL HEPATIC SPECT/CT IMAGING USING TECHNETIUM-99M MACRO-AGGREGATED ALBUMIN IN PREPARATION FOR RADIOEMBOLIZATION.
    J Nucl Med. 2015 Jun 18. pii: jnumed.114.153346.
    PubMed     Text format     Abstract available


  210. ZANOTTI-FREGONARA P, Laforest R, Wallis JW
    Fetal radiation dose from [18F]-FDG in pregnant patients imaged with PET, PET/CT and PET/MRI.
    J Nucl Med. 2015 Jun 18. pii: jnumed.115.157032.
    PubMed     Text format     Abstract available


  211. LUBBERINK M, Golla SS, Jonasson M, Rubin K, et al
    The water-perfusable tissue fraction of colorectal cancer metastases is increased by the selective PDGF-receptor inhibitor imatinib but not the IL-1 receptor antagonist anakinra, a study using serial dynamic 15O-water PET.
    J Nucl Med. 2015 Jun 11. pii: jnumed.114.151894.
    PubMed     Text format     Abstract available


  212. ETCHEBEHERE E, Araujo JC, Fox PS, Swanston NM, et al
    Prognostic factors in patients treated with radium-223: the role of skeletal tumor burden on baseline 18F-fluoride-PET/CT in predicting overall survival.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.158626.
    PubMed     Text format     Abstract available


  213. BLYKERS A, Schoonooghe S, Xavier C, D'hoe K, et al
    PET imaging of MMR-expressing macrophages in tumor stroma using 18F-radiolabeled camelid single-domain antibody fragments.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.156828.
    PubMed     Text format     Abstract available


  214. ROWE SP, Gage KL, Faraj SF, Macura K, et al
    18F-DCFBC PET/CT for PSMA-based Detection and Characterization of Primary Prostate Cancer.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.154336.
    PubMed     Text format     Abstract available


  215. KIM DY, Kim HS, Reder S, Zheng JH, et al
    Comparison of 18F-labeled Fluoroalkylphosphonium Cations with 13N-NH3 for PET Myocardial Perfusion Imaging.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.156794.
    PubMed     Text format     Abstract available


  216. HEIDARI P, Esfahani S, Turker NS, Wong G, et al
    Imaging of the secreted extracellular periostin, an important marker of invasion in tumor microenvironment in esophageal cancer.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.156216.
    PubMed     Text format     Abstract available


  217. KAUHANEN S, Rinta-Kiikka I, Kemppainen J, Gronroos J, et al
    The diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT), multidetector row computed tomography (MDCT) and magnetic resonance imaging (MRI) in the diagnosis of pancreatic cysts; a prospectiv
    J Nucl Med. 2015 Jun 4. pii: jnumed.114.148940.
    PubMed     Text format     Abstract available


  218. HIRATA K, Hattori N, Takeuchi W, Shiga T, et al
    Metabolic activity of red nucleus and its correlation with cerebral cortex and cerebellum - a study using a high-resolution semiconductor PET system.
    J Nucl Med. 2015 Jun 4. pii: jnumed.114.152504.
    PubMed     Text format     Abstract available


  219. HUSBY JA, Reitan BC, Biermann M, Trovik J, et al
    Metabolic tumor volume (MTV) at 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG-PET/CT) improves preoperative identification of high-risk endometrial carcinoma patients.
    J Nucl Med. 2015 Jun 4. pii: jnumed.115.159913.
    PubMed     Text format     Abstract available


  220. GROHEUX D, Hindie E
    Breast cancer staging: to which women 18FDG-PET/CT should be offered?
    J Nucl Med. 2015 Jun 4. pii: jnumed.115.160945.
    PubMed     Text format    


  221. CHEN YJ, Rosario BL, Mowrey W, Laymon CM, et al
    PiB Relative Delivery (R1) as a Proxy of Relative Cerebral Blood Flow: Quantitative Evaluation Using Single Session 15O-Water and 11C-PiB PET.
    J Nucl Med. 2015 Jun 4. pii: jnumed.114.152405.
    PubMed     Text format     Abstract available


  222. PALNER M, Shen B, Jeon J, Lin J, et al
    Preclinical kinetic analysis of the Caspase-3/7 PET tracer 18F-C-SNAT for imaging tumor apoptosis after chemotherapeutic treatment.
    J Nucl Med. 2015 Jun 4. pii: jnumed.115.155259.
    PubMed     Text format     Abstract available


  223. DIMITRIU-LEEN AC, Scholte AJ, Jacobson AF
    123I-MIBG SPECT for Evaluation of Patients with Heart Failure.
    J Nucl Med. 2015;56 Suppl 4:25S-30S.
    PubMed     Text format     Abstract available


  224. HAROLDS JA, Oates ME, Guiberteau MJ, Ghesani M, et al
    New training pathways to dual certification in nuclear medicine and radiology.
    J Nucl Med. 2015;56:17N-8N.
    PubMed     Text format    


  225. GARIN E, Edeline J
    Reply: Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
    J Nucl Med. 2015;56:969.
    PubMed     Text format    


  226. HOFMAN MS, Michael M, Kashyap R, Hicks RJ, et al
    Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
    J Nucl Med. 2015;56:968-9.
    PubMed     Text format    


  227. BORGQUIST R, Singh JP
    An electrophysiologist perspective on risk stratification in heart failure: can better understanding of the condition of the cardiac sympathetic nervous system help?
    J Nucl Med. 2015;56 Suppl 4:59S-64S.
    PubMed     Text format     Abstract available


  228. ABDULGHANI M, Duell J, Smith M, Chen W, et al
    Global and Regional Myocardial Innervation Before and After Ablation of Drug-Refractory Ventricular Tachycardia Assessed with 123I-MIBG.
    J Nucl Med. 2015;56 Suppl 4:52S-58S.
    PubMed     Text format     Abstract available


  229. LEVINE A, Hecht HS
    Cardiac CT Angiography in Congestive Heart Failure.
    J Nucl Med. 2015;56 Suppl 4:46S-51S.
    PubMed     Text format     Abstract available


  230. JACOBSON AF, Narula J
    Introduction to cardiac neuronal imaging: a clinical perspective.
    J Nucl Med. 2015;56 Suppl 4:3S-6S.
    PubMed     Text format     Abstract available


  231. NAKAJIMA K, Nakata T
    Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan.
    J Nucl Med. 2015;56 Suppl 4:11S-19S.
    PubMed     Text format     Abstract available



  232. Deadlines for Appropriate Use Criteria loom; resolutions remain unclear.
    J Nucl Med. 2015;56:23N-24N.
    PubMed     Text format    


  233. SEGALL G
    ABNM Maintenance of Certification: Getting It Right.
    J Nucl Med. 2015;56:19N.
    PubMed     Text format    


  234. DHAWAN V, Robeson W, Bjelke D, Chaly T, et al
    Human Radiation Dosimetry for the N-Methyl-D-Aspartate Receptor Radioligand 11C-CNS5161.
    J Nucl Med. 2015;56:869-72.
    PubMed     Text format     Abstract available


  235. FAHEY FH, Ziniel SI, Manion D, Treves ST, et al
    Effects of Image Gently and the North American guidelines: administered activities in children at 13 North American pediatric hospitals.
    J Nucl Med. 2015;56:962-7.
    PubMed     Text format     Abstract available


  236. MONCAYO VM, Aarsvold JN, Alazraki NP
    Lymphoscintigraphy and sentinel nodes.
    J Nucl Med. 2015;56:901-7.
    PubMed     Text format     Abstract available


  237. PRINCE JF, van Rooij R, Bol GH, de Jong HW, et al
    Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres.
    J Nucl Med. 2015;56:817-23.
    PubMed     Text format     Abstract available


  238. JIANG L, Tu Y, Kimura RH, Habte F, et al
    64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques.
    J Nucl Med. 2015;56:939-44.
    PubMed     Text format     Abstract available


  239. JUNG JJ, Razavian M, Challa AA, Nie L, et al
    Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.
    J Nucl Med. 2015;56:933-8.
    PubMed     Text format     Abstract available


  240. HERRMANN K, Bluemel C, Weineisen M, Schottelius M, et al
    Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy.
    J Nucl Med. 2015;56:855-61.
    PubMed     Text format     Abstract available


  241. VAN BERKEL A, Rao JU, Lenders JW, Pellegata NS, et al
    Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    J Nucl Med. 2015;56:839-46.
    PubMed     Text format     Abstract available


  242. PELLETIER-GALARNEAU M, Sogbein OO, Pham X, Hao J, et al
    Multicenter validation of a shortened gastric-emptying protocol.
    J Nucl Med. 2015;56:873-6.
    PubMed     Text format     Abstract available


  243. LIN C, Kume K, Mori T, Martinez ME, et al
    Predictive Value of Early-Stage Uptake of 3'-Deoxy-3'-18F-Fluorothymidine in Cancer Cells Treated with Charged Particle Irradiation.
    J Nucl Med. 2015;56:945-50.
    PubMed     Text format     Abstract available


    May 2015
  244. PAULUS DH, Quick HH, Geppert C, Fenchel M, et al
    Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including Bone.
    J Nucl Med. 2015 May 29. pii: jnumed.115.156000.
    PubMed     Text format     Abstract available


  245. ANTWI K, Fani M, Nicolas G, Rottenburger C, et al
    Localization of hidden Insulinomas with 68Ga-DOTA-exendin-4 PET/CT: A Pilot Study.
    J Nucl Med. 2015 May 21. pii: jnumed.115.157768.
    PubMed     Text format     Abstract available


  246. ROWE SP, Vicente E, Anizan N, Wang H, et al
    Repeatability of radiotracer uptake in normal abdominal organs with 111In-pentetreotide quantitative SPECT/CT.
    J Nucl Med. 2015 May 14. pii: jnumed.115.155358.
    PubMed     Text format     Abstract available


  247. HWANG H, Jeong HS, Oh PS, Na KS, et al
    Improving Cerebral Blood Flow through Liposomal Delivery of Angiogenic Peptides: Potential of 18F-FDG PET Imaging in Ischemic Stroke Treatment.
    J Nucl Med. 2015 May 14. pii: jnumed.115.154443.
    PubMed     Text format     Abstract available


  248. JADVAR H
    PSMA PET in Prostate Cancer.
    J Nucl Med. 2015 May 14. pii: jnumed.115.157339.
    PubMed     Text format    


  249. BLASI F, Oliveira BL, Rietz TA, Rotile NJ, et al
    Radiation dosimetry of the fibrin-binding probe 64Cu-FBP8 and its feasibility for positron emission tomography imaging of deep vein thrombosis and pulmonary embolism in rats.
    J Nucl Med. 2015 May 14. pii: jnumed.115.157982.
    PubMed     Text format     Abstract available


  250. HUSMANN L, Sah BR, Scherrer A, Burger IA, et al
    18F-FDG-PET/CT FOR THERAPY CONTROL IN VASCULAR GRAFT INFECTIONS: A FIRST FEASIBILITY STUDY.
    J Nucl Med. 2015 May 14. pii: jnumed.115.156265.
    PubMed     Text format     Abstract available


  251. NIEDERMOSER S, Chin J, Waengler C, Kostikov A, et al
    In vivo Evaluation of 18F-SiFAlin modified TATE: A Potential Challenge for 68Ga- DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with Positron Emission Tomography (PET).
    J Nucl Med. 2015 May 14. pii: jnumed.114.149583.
    PubMed     Text format     Abstract available


  252. CHATALIC KL, Veldhoven-Zweistra J, Bolkestein M, Hoeben S, et al
    A novel 111In-labeled anti-PSMA nanobody for targeted SPECT/CT imaging of prostate cancer.
    J Nucl Med. 2015 May 14. pii: jnumed.115.156729.
    PubMed     Text format     Abstract available


  253. MANBER R, Thielemans K, Hutton B, Barnes A, et al
    Practical PET Respiratory Motion Correction in Clinical PET/MR.
    J Nucl Med. 2015 May 7. pii: jnumed.114.151779.
    PubMed     Text format     Abstract available


  254. BEZRUKOV I, Schmidt H, Gatidis S, Mantlik F, et al
    Quantitative evaluation of segmentation- and atlas-based attenuation correction for PET/MR on pediatric patients.
    J Nucl Med. 2015 May 7. pii: jnumed.114.149476.
    PubMed     Text format     Abstract available


  255. MARCUS C, Marashdeh W, Ahn SJ, Taghipour M, et al
    FDG PET/CT & Colorectal Cancer: Value of Fourth and Subsequent Post Therapy follow up scans for Patient Management.
    J Nucl Med. 2015 May 7. pii: jnumed.115.156240.
    PubMed     Text format     Abstract available


  256. FIZ F, Morbelli S, Piccardo A, Bauckneht M, et al
    18F-NaF uptake by the atherosclerotic plaque at PET/CT imaging: inverse correlation between calcification density and mineral metabolic activity.
    J Nucl Med. 2015 May 7. pii: jnumed.115.154229.
    PubMed     Text format     Abstract available


  257. PFEIFER A, Knigge U, Binderup T, Mortensen J, et al
    64Cu-DOTATATE PET for Neuroendocrine Tumors: a Prospective Head-to-Head Comparison with 111In-DTPA-octreotide in 112 Patients.
    J Nucl Med. 2015 May 7. pii: jnumed.115.156539.
    PubMed     Text format     Abstract available


  258. GOENSE L, van Rossum PS, Reitsma JB, Lam MG, et al
    Diagnostic performance of 18F-FDG and PET/CT for the detection of recurrent esophageal cancer after treatment with curative intent: a systematic review and meta-analysis.
    J Nucl Med. 2015 May 7. pii: jnumed.115.155580.
    PubMed     Text format     Abstract available


  259. DELBEKE D
    The Era of Evidence-Based Medicine: What Are the Implications for JNM and Other Imaging Journals?
    J Nucl Med. 2015;56:28A.
    PubMed     Text format    


  260. HERSCOVITCH P
    Amyloid Imaging Coverage with Evidence Development and the IDEAS Study.
    J Nucl Med. 2015;56:20N.
    PubMed     Text format    


  261. KHALKHALI I
    Ismael Mena, MD, 1928-2015.
    J Nucl Med. 2015;56:19N.
    PubMed     Text format    


  262. CONTI PS
    Walter Wolf, PhD, 1931-2014.
    J Nucl Med. 2015;56:13N.
    PubMed     Text format    


  263. ZAMAN RT, Kosuge H, Carpenter C, Sun C, et al
    Scintillating balloon-enabled fiber-optic system for radionuclide imaging of atherosclerotic plaques.
    J Nucl Med. 2015;56:771-7.
    PubMed     Text format     Abstract available


  264. LAVERMAN P, van der Geest T, Terry SY, Gerrits D, et al
    Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis.
    J Nucl Med. 2015;56:778-83.
    PubMed     Text format     Abstract available


  265. HINDIE E, Zanotti-Fregonara P, Tabarin A, Rubello D, et al
    The role of radionuclide imaging in the surgical management of primary hyperparathyroidism.
    J Nucl Med. 2015;56:737-44.
    PubMed     Text format     Abstract available


  266. FAN Z, Harold D, Pasqualetti G, Williams J, et al
    Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?
    J Nucl Med. 2015;56:707-13.
    PubMed     Text format     Abstract available


  267. KHAIRNAR A, Marchand F, Vidal A, Etienne M, et al
    99mTc-NTP 15-5 Imaging for Cartilage Involvement in Experimental Rheumatoid Arthritis: Comparison with Routinely Used Molecular Imaging Methods and Sensitivity to Chronic Nonsteroidal Antiinflammatory Drug Treatment.
    J Nucl Med. 2015;56:798-804.
    PubMed     Text format     Abstract available


  268. HAUSNER SH, Bauer N, Hu LY, Knight LM, et al
    The Effect of Bi-Terminal PEGylation of an Integrin alphavbeta(6)-Targeted (1)(8)F Peptide on Pharmacokinetics and Tumor Uptake.
    J Nucl Med. 2015;56:784-90.
    PubMed     Text format     Abstract available


  269. FAZIO P, Svenningsson P, Forsberg A, Jonsson EG, et al
    Quantitative Analysis of (1)(8)F-(E)-N-(3-Iodoprop-2-Enyl)-2beta-Carbofluoroethoxy-3beta-(4'-Methyl-Phenyl ) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
    J Nucl Med. 2015;56:714-20.
    PubMed     Text format     Abstract available


  270. GLAUDEMANS AW, Slart RH, van Dijl JM, van Oosten M, et al
    Molecular imaging of infectious and inflammatory diseases: a terra incognita.
    J Nucl Med. 2015;56:659-61.
    PubMed     Text format    


    April 2015
  271. MAZERE J, Mayo W, Pariscoat G, Schulz J, et al
    Simplified quantification method for in vivo SPECT imaging of the Vesicular Acetylcholine Transporter with 123I-IBVM.
    J Nucl Med. 2015 Apr 23. pii: jnumed.114.147074.
    PubMed     Text format     Abstract available


  272. WANG H, Li D, Liu S, Liu R, et al
    Small animal PET imaging of pancreatic cancer xenografts using 64Cu labeled monoclonal antibody MAb159.
    J Nucl Med. 2015 Apr 23. pii: jnumed.115.155812.
    PubMed     Text format     Abstract available


  273. RUDD JH, Coughlin PA, Groves A
    Predicting aortic aneurysm expansion by PET.
    J Nucl Med. 2015 Apr 23. pii: jnumed.115.154062.
    PubMed     Text format    


  274. FAYAD H, Schmidt H, Wurslin C, Visvikis D, et al
    Reconstruction incorporated respiratory motion correction in clinical simultaneous PET/MR imaging for oncology applications.
    J Nucl Med. 2015 Apr 23. pii: jnumed.114.153007.
    PubMed     Text format     Abstract available


  275. WEBER WA, Gatsonis CA, Mozley PD, Hanna LG, et al
    Repeatability of 18F-FDG PET/CT in Advanced Non-small Cell Lung Cancer: Prospective Assessment in Two Multicenter Trials.
    J Nucl Med. 2015 Apr 23. pii: jnumed.114.147728.
    PubMed     Text format     Abstract available


  276. MEDINA RA, Mariotti E, Pavlovic D, Shaw KP, et al
    64CuCTS: a promising radiopharmaceutical for the identification of low grade cardiac hypoxia by PET.
    J Nucl Med. 2015 Apr 16. pii: jnumed.114.148353.
    PubMed     Text format     Abstract available


  277. SHI S, Orbay H, Yang Y, Graves SA, et al
    PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment.
    J Nucl Med. 2015 Apr 16. pii: jnumed.114.153098.
    PubMed     Text format     Abstract available


  278. GRAHAM MM, Wahl RL, Hoffman JM, Yap JT, et al
    Summary of the UPICT Protocol for FDG PET/CT Imaging in Oncology Clinical Trials.
    J Nucl Med. 2015 Apr 16. pii: jnumed.115.158402.
    PubMed     Text format     Abstract available


  279. BENESOVA M, Schafer M, Bauder-Wust U, Afshar-Oromieh A, et al
    Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer.
    J Nucl Med. 2015 Apr 16. pii: jnumed.114.147413.
    PubMed     Text format     Abstract available


  280. GROHEUX D, Sanna A, Majdoub M, de Cremoux P, et al
    Baseline tumor 18FDG uptake and modifications after 2 cycles of neoadjuvant chemotherapy are prognostic of outcome in ER+/HER2- breast cancer.
    J Nucl Med. 2015 Apr 16. pii: jnumed.115.154138.
    PubMed     Text format     Abstract available


  281. AZARBAR S, Salardini A, Dahdah N, Lazewatsky J, et al
    A phaseI-II, open-label, multi-center trial to determine the dosimetry and safety of Technetium Tc99m Sestamibi in pediatric subjects.
    J Nucl Med. 2015 Apr 9. pii: jnumed.114.146795.
    PubMed     Text format     Abstract available


  282. MEHRANIAN A, Zaidi H
    Clinical assessment of emission- and segmentation-based MRI-guided attenuation correction in whole-body TOF PET/MRI.
    J Nucl Med. 2015 Apr 9. pii: jnumed.115.154807.
    PubMed     Text format     Abstract available


  283. HOOGENDAM JP, Veldhuis WB, Hobbelink MG, Verheijen RH, et al
    Technetium-99m SPECT-CT versus planar lymphoscintigraphy for preoperative sentinel lymph node detection in cervical cancer: a systematic review and meta-analysis.
    J Nucl Med. 2015 Apr 9. pii: jnumed.114.152439.
    PubMed     Text format     Abstract available


  284. MCHUGH CI, Shields AF
    FLT-PET Evaluation of Radiation Response.
    J Nucl Med. 2015 Apr 9. pii: jnumed.115.155507.
    PubMed     Text format    


  285. RATIB O
    Shine-through artifact in PET/MRI: a perspective on its impact in clinical applications of PET-MR.
    J Nucl Med. 2015 Apr 9. pii: jnumed.115.155135.
    PubMed     Text format    


  286. LUO H, Hong H, Slater MR, Graves SA, et al
    PET of c-Met in cancer with 64Cu-labeled Hepatocyte Growth Factor.
    J Nucl Med. 2015 Apr 3. pii: jnumed.115.154690.
    PubMed     Text format     Abstract available


  287. INOUE Y, Nagahara K, Tanaka Y, Miyatake H, et al
    Methods of CT dose estimation in whole-body 18F-FDG PET/CT.
    J Nucl Med. 2015 Apr 3. pii: jnumed.114.153718.
    PubMed     Text format     Abstract available


  288. MINAMIMOTO R, Mosci C, Jamali M, Barkhodari A, et al
    Semiquantitative Analysis of the Biodistribution of the Combined 18F-NaF and 18F-FDG Administration for PET/CT Imaging.
    J Nucl Med. 2015 Apr 3. pii: jnumed.115.153767.
    PubMed     Text format     Abstract available


  289. WELLS RG, Wei L, Petryk J, Duan Y, et al
    Flow-dependent uptake of I-123-CMICE-013, a novel SPECT perfusion agent, compared to standard tracers.
    J Nucl Med. 2015 Apr 3. pii: jnumed.114.151563.
    PubMed     Text format     Abstract available


  290. MOSLEY M, Knight J, Neesse A, Michl P, et al
    Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer.
    J Nucl Med. 2015 Apr 3. pii: jnumed.114.152496.
    PubMed     Text format     Abstract available



  291. Canadian NRU extended; medical isotope partnership announced.
    J Nucl Med. 2015;56:9N.
    PubMed     Text format    


  292. PAPPAS V
    SNMMI leadership update: SNMMI annual meeting heads to Baltimore.
    J Nucl Med. 2015;56:13N.
    PubMed     Text format    


  293. FAHEY F
    History Corner: from the new SNMMI historian.
    J Nucl Med. 2015;56:11N.
    PubMed     Text format    


  294. DORBALA S, Blankstein R, Skali H, Park MA, et al
    Approaches to reducing radiation dose from radionuclide myocardial perfusion imaging.
    J Nucl Med. 2015;56:592-9.
    PubMed     Text format     Abstract available


  295. HUA C, Merchant TE, Li X, Li Y, et al
    Establishing age-associated normative ranges of the cerebral 18F-FDG uptake ratio in children.
    J Nucl Med. 2015;56:575-9.
    PubMed     Text format     Abstract available


  296. BANERJEE SR, Foss CA, Pullambhatla M, Wang Y, et al
    Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates.
    J Nucl Med. 2015;56:628-34.
    PubMed     Text format     Abstract available


  297. KOCH CJ, Evans SM
    Pharmacokinetic and pharmacodynamic modifiers of EF5 uptake and binding.
    J Nucl Med. 2015;56:653.
    PubMed     Text format    


  298. CHITNENI SK, Bida GT, Zalutsky MR, Dewhirst MW, et al
    Reply: Pharmacokinetic and Pharmacodynamic Modifiers of EF5 Uptake and Binding.
    J Nucl Med. 2015;56:653-4.
    PubMed     Text format    


    March 2015
  299. NAGARAJAH J, Ho AL, Tuttle RM, Weber WA, et al
    Correlation of BRAFV600E mutation and glucose metabolism in thyroid cancer patients: An 18F-FDG-PET study.
    J Nucl Med. 2015 Mar 26. pii: jnumed.114.150607.
    PubMed     Text format     Abstract available


  300. HANAOKA H, Ohshima Y, Suzuki Y, Yamaguchi A, et al
    Development of a Widely Usable Amino Acid Tracer: 76Br-alpha-Methyl-Phenylalanine for Tumor PET Imaging.
    J Nucl Med. 2015 Mar 26. pii: jnumed.114.152215.
    PubMed     Text format     Abstract available


  301. JAMAR F, Lhommel R
    Interim 18F-FDG-PET in diffuse large B-cell lymphoma : emerging worldwide?
    J Nucl Med. 2015 Mar 19. pii: jnumed.114.151183.
    PubMed     Text format    


  302. MOREL O, Mandry D, Micard E, Kauffmann C, et al
    Evidence of cyclic changes in the metabolism of abdominal aortic aneurysms during growth phases: a FDG-PET sequential observational study.
    J Nucl Med. 2015 Mar 19. pii: jnumed.114.146415.
    PubMed     Text format     Abstract available


  303. EIBER M, Maurer T, Souvatzoglou M, Beer AJ, et al
    Evaluation of hybrid 68Ga-PSMA-ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy.
    J Nucl Med. 2015 Mar 19. pii: jnumed.115.154153.
    PubMed     Text format     Abstract available


  304. DALM SU, Martens JW, Sieuwerts AM, van Deurzen CH, et al
    IN-VITRO AND IN-VIVO APPLICATION OF RADIOLABELED GASTRIN RELEASING PEPTIDE RECEPTOR LIGANDS IN BREAST CANCER.
    J Nucl Med. 2015 Mar 19. pii: jnumed.114.153023.
    PubMed     Text format     Abstract available


  305. FAHEY FH, Bom HH, Chiti A, Choi YY, et al
    Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 1: Statement of the Issue and a Review of Available Resources.
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.152249.
    PubMed     Text format     Abstract available


  306. LYOO CH, Ikawa M, Liow JS, Zoghbi SS, et al
    Cerebellum can serve as a pseudo-reference region in Alzheimer's disease to detect neuroinflammation measured with PET radioligand binding to translocator protein (TSPO).
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.146027.
    PubMed     Text format     Abstract available


  307. KOLB A, Sauter AW, Eriksson LA, Vandenbrouke A, et al
    Shine-through in PET/MRI: effects of the magnetic field on positron range and subsequent image artifacts.
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.147637.
    PubMed     Text format     Abstract available


  308. SCHWARZ SW, Oyama R
    The Role of Exploratory INDs for Translating Radiopharmaceuticals into First-In-Human Studies.
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.146472.
    PubMed     Text format     Abstract available


  309. TSENG JR, Lin CW, Chen SH, Yen TH, et al
    Clinical Usefulness of FDG PET/CT for the Detection of Infections of Unknown Origin in Patients Undergoing Maintenance Hemodialysis.
    J Nucl Med. 2015 Mar 12. pii: jnumed.114.151696.
    PubMed     Text format     Abstract available


  310. LANDAU SM, Fero A, Baker SL, Koeppe RA, et al
    Measurement of longitudinal A#946; change with 18F florbetapir PET and standard uptake value ratios.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.148981.
    PubMed     Text format     Abstract available


  311. KANEKO Y, Murray WK, Link E, Hicks RJ, et al
    Improving patient selection for FDG-PET scanning in the staging of gastric cancer.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.150946.
    PubMed     Text format     Abstract available


  312. CHEN K, Roontiva A, Thiyyagura P, Lee W, et al
    Improved power to characterize longitudinal amyloid-beta PET changes and evaluate amyloid-modifying treatments using a cerebral white matter reference region.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.149732.
    PubMed     Text format     Abstract available


  313. MEHRANIAN A, Zaidi H
    Impact of time-of-flight PET on quantification errors in MRI-based attenuation correction.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.148817.
    PubMed     Text format     Abstract available


  314. EINSTEIN AJ, Johnson LL, DeLuca A, Kontak AC, et al
    Radiation Dose and Prognosis of Ultra-Low Dose Stress-First Myocardial Perfusion SPECT in Patients with Chest Pain Using a High-Efficiency Camera.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.150664.
    PubMed     Text format     Abstract available


  315. JADVAR H, Subramaniam R, Berman CG, Boada F, et al
    American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MRI: Brain.
    J Nucl Med. 2015 Mar 5. pii: jnumed.115.155218.
    PubMed     Text format    


  316. LIN KS, Amouroux G, Pan J, Zhang Z, et al
    Comparative Studies of Three Gallium-68-labeled [des-Arg10]Kallidin Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.152132.
    PubMed     Text format     Abstract available


  317. KNOOP K, Schwenk N, Schmohl K, Muller A, et al
    Mesenchymal stem cell (MSC)-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.146662.
    PubMed     Text format     Abstract available


  318. FREY KA
    Amyloid imaging in dementia: contribution or confusion?
    J Nucl Med. 2015;56:331-2.
    PubMed     Text format    


  319. THRALL JH
    Misinterpretation of 18F-FDG studies in oncology.
    J Nucl Med. 2015;56:494.
    PubMed     Text format    


  320. DELBEKE D
    JNM update for 2014.
    J Nucl Med. 2015;56:25A.
    PubMed     Text format    


  321. HERSCOVITCH P
    SNMMI leadership update: reaching out to develop a unified voice.
    J Nucl Med. 2015;56:16N.
    PubMed     Text format    



  322. Enrollment trends in technologist training.
    J Nucl Med. 2015;56:15N.
    PubMed     Text format    



  323. SNMMI industry forum created to work together on areas of promise.
    J Nucl Med. 2015;56:13N.
    PubMed     Text format    


  324. HERRMANN K, Lapa C, Wester HJ, Schottelius M, et al
    Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.
    J Nucl Med. 2015;56:410-6.
    PubMed     Text format     Abstract available


  325. GARIN E, Rolland Y, Edeline J, Icard N, et al
    Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
    J Nucl Med. 2015;56:339-46.
    PubMed     Text format     Abstract available


  326. DELSO G, Wiesinger F, Sacolick LI, Kaushik SS, et al
    Clinical evaluation of zero-echo-time MR imaging for the segmentation of the skull.
    J Nucl Med. 2015;56:417-22.
    PubMed     Text format     Abstract available


  327. KLUPP E, Grimmer T, Tahmasian M, Sorg C, et al
    Prefrontal hypometabolism in Alzheimer disease is related to longitudinal amyloid accumulation in remote brain regions.
    J Nucl Med. 2015;56:399-404.
    PubMed     Text format     Abstract available


  328. CABELLO J, Lukas M, Forster S, Pyka T, et al
    MR-based attenuation correction using ultrashort-echo-time pulse sequences in dementia patients.
    J Nucl Med. 2015;56:423-9.
    PubMed     Text format     Abstract available


  329. CZUPRYNA J, Kachur AV, Blankemeyer E, Popov AV, et al
    Cerenkov-specific contrast agents for detection of pH in vivo.
    J Nucl Med. 2015;56:483-8.
    PubMed     Text format     Abstract available


  330. STEPHENSON NA, Holland JP, Kassenbrock A, Yokell DL, et al
    Iodonium ylide-mediated radiofluorination of 18F-FPEB and validation for human use.
    J Nucl Med. 2015;56:489-92.
    PubMed     Text format     Abstract available


  331. TIMMERMAND OV, Tran TA, Strand SE, Axelsson J, et al
    Intratherapeutic biokinetic measurements, dosimetry parameter estimates, and monitoring of treatment efficacy using cerenkov luminescence imaging in preclinical radionuclide therapy.
    J Nucl Med. 2015;56:444-9.
    PubMed     Text format     Abstract available


  332. LAUTAMAKI R, Sasano T, Higuchi T, Nekolla SG, et al
    Multiparametric molecular imaging provides mechanistic insights into sympathetic innervation impairment in the viable infarct border zone.
    J Nucl Med. 2015;56:457-63.
    PubMed     Text format     Abstract available


  333. GIORGETTI A, Burchielli S, Positano V, Kovalski G, et al
    Dynamic 3D analysis of myocardial sympathetic innervation: an experimental study using 123I-MIBG and a CZT camera.
    J Nucl Med. 2015;56:464-9.
    PubMed     Text format     Abstract available


  334. NAHIMI A, Jakobsen S, Munk OL, Vang K, et al
    Mapping alpha2 adrenoceptors of the human brain with 11C-yohimbine.
    J Nucl Med. 2015;56:392-8.
    PubMed     Text format     Abstract available


    February 2015
  335. HUET P, Burg S, Le Guludec D, Hyafil F, et al
    Variability and uncertainty of FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.142596.
    PubMed     Text format     Abstract available


  336. CHEN W, Dilsizian V
    PET Assessment of Vascular Inflammation and Atherosclerotic Plaques: SUV or TBR?
    J Nucl Med. 2015 Feb 26. pii: jnumed.115.154385.
    PubMed     Text format    


  337. SU Z, Roncaroli F, Durrenberger PF, Coope DJ, et al
    The 18-kDa Mitochondrial Translocator Protein in Human Gliomas: A 11C-(R)PK11195 PET Imaging and Neuropathology Study.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.151621.
    PubMed     Text format     Abstract available


  338. FANCHON LM, Dogan S, Moreira AL, Carlin SA, et al
    Feasibility for in situ, High Resolution Correlation of Tracer Uptake with Histopathology by Quantitative Autoradiography of Biopsy Specimens Obtained under FDG PET/CT Guidance.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.148668.
    PubMed     Text format     Abstract available


  339. FENDLER WP, Lehmann M, Todica AS, Herrmann K, et al
    PET response criteria (PERCIST) predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.152462.
    PubMed     Text format     Abstract available


  340. ZHANG G, Li J, Wang X, Ma Y, et al
    The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: A pilot study.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.148254.
    PubMed     Text format     Abstract available


  341. JACOBSON O, Yan X, Gang N, Weiss ID, et al
    PET Imaging of Tenascin-C with a Radiolabeled Single-Strand DNA Aptamer.
    J Nucl Med. 2015 Feb 19. pii: jnumed.114.149484.
    PubMed     Text format     Abstract available


  342. BARRET O, Hannestad J, Vala C, Alagille D, et al
    Characterization in humans of 18F-MNI-444, a novel PET radiotracer for brain adenosine A2A receptors.
    J Nucl Med. 2015 Feb 19. pii: jnumed.114.152546.
    PubMed     Text format     Abstract available


  343. BIEGON A, Alexoff D, Kim SW, Logan J, et al
    Aromatase Imaging with [N-methyl-C-11]vorozole PET in Healthy Men and Women.
    J Nucl Med. 2015 Feb 19. pii: jnumed.114.150383.
    PubMed     Text format     Abstract available


  344. GURALNIK L, Rozenberg R, Frenkel A, Israel O, et al
    Metabolic PET/CT guided lung lesion biopsies - impact on diagnostic accuracy and rate of sampling error.
    J Nucl Med. 2015 Feb 19. pii: jnumed.113.131466.
    PubMed     Text format     Abstract available


  345. HOFMAN MS, Binns D, Johnston V, Siva S, et al
    Ga-68 EDTA PET/CT imaging and plasma clearance for glomerular filtration rate (GFR) quantification: comparison to conventional Cr-51 EDTA.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.147843.
    PubMed     Text format     Abstract available


  346. IVASHCHENKO O, van der Have F, Goorden M, Ramakers R, et al
    Ultra-high-sensitivity sub-mm mouse SPECT.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.147140.
    PubMed     Text format     Abstract available


  347. RAUSCHER I, Beer A, Schaeffeler C, Souvatzoglou M, et al
    Evaluation of 18F-Fluoride PET/MR and PET/CT in patients with unclear foot pain.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.150532.
    PubMed     Text format     Abstract available


  348. SAH BR, Burger IA, Schibli R, Friebe M, et al
    Dosimetry and first clinical evaluation of the new 18F radiolabeled Bombesin Analogue BAY 864367 in patients with prostate cancer.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.147116.
    PubMed     Text format     Abstract available


  349. VERWER EE, Oprea-Lager DE, van den Eertwegh AJ, van Moorselaar RJ, et al
    Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.148007.
    PubMed     Text format     Abstract available


  350. WITHOFS N, Signolle N, Somja J, Lovinfosse P, et al
    18F-FPRGD2 PET/CT imaging of integrin alphavbeta3 in renal carcinomas: Correlation with histopathology.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.149021.
    PubMed     Text format     Abstract available


  351. BEIJST C, Elschot M, Viergever MA, de Jong HW, et al
    A parallel cone collimator for high-energy SPECT.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.149658.
    PubMed     Text format     Abstract available


  352. CHIRINDEL A, Chaudhry M, Blakeley J, Wahl RL, et al
    18F-FDG PET/CT qualitative and quantitative evaluation in NF1 patients for Detection of Malignant Transformation - comparison of early to delayed imaging with and without liver activity normalization.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.142372.
    PubMed     Text format     Abstract available


  353. KOBYLECKI C, Langheinrich T, Hinz R, Vardy E, et al
    18F-florbetapir positron emission tomography in patients with frontotemporal dementia and Alzheimer's disease.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.147454.
    PubMed     Text format     Abstract available


  354. ILHAN H, Goritschan A, Paprottka P, Jakobs TF, et al
    Systematic evaluation of tumoral [Tc-99m]MAA-uptake using SPECT and SPECT/CT in 502 patients prior to Y-90 radioembolization.
    J Nucl Med. 2015 Feb 5. pii: jnumed.114.150565.
    PubMed     Text format     Abstract available


  355. BAGEAC A
    Commentary: Quality: commandment and conundrum.
    J Nucl Med. 2015;56:9N-10N.
    PubMed     Text format    


  356. PAPPAS V
    SNMMI leadership update: Clinical Trials Network: from clinical trials to practice.
    J Nucl Med. 2015;56:12N.
    PubMed     Text format    


  357. PARKER JA
    ABNM international In-Training Examination program.
    J Nucl Med. 2015;56:10N.
    PubMed     Text format    


  358. WONDERGEM MJ, Rizvi SN, Jauw Y, Hoekstra OS, et al
    18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.
    J Nucl Med. 2015;56:216-21.
    PubMed     Text format     Abstract available


  359. BAKKER G, Vingerhoets WA, van Wieringen JP, de Bruin K, et al
    123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo.
    J Nucl Med. 2015;56:317-22.
    PubMed     Text format     Abstract available


  360. ILAN E, Sandstrom M, Wassberg C, Sundin A, et al
    Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE.
    J Nucl Med. 2015;56:177-82.
    PubMed     Text format     Abstract available


  361. ISHIBASHI K, Onishi A, Fujiwara Y, Ishiwata K, et al
    Relationship between Alzheimer disease-like pattern of 18F-FDG and fasting plasma glucose levels in cognitively normal volunteers.
    J Nucl Med. 2015;56:229-33.
    PubMed     Text format     Abstract available



  362. Abstracts of the AACR/SNMMI State-of-the-Art Molecular Imaging in Cancer Biology and Therapy, February 11-14, 2015, San Diego, CA.
    J Nucl Med. 2015;56 Suppl 1:3A-28.
    PubMed     Text format    


    January 2015
  363. YU EY, Duan F, Muzi M, Deng X, et al
    Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: Results from ACRIN 6687.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.146936.
    PubMed     Text format     Abstract available


  364. LEE SI, Catalano OA, Dehdashti F
    Gynecologic Cancer Imaging with MRI, FDG PET-CT and PET-MR.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.145011.
    PubMed     Text format     Abstract available


  365. RACHINGER W, Stoecklein VM, Terpolilli NA, Haug AR, et al
    Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumorfree tissue.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.149120.
    PubMed     Text format     Abstract available


  366. WALRAND S, Hesse M, Lhommel R, Jamar F, et al
    About the impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.152017.
    PubMed     Text format    


  367. MAKRIS NE, Boellaard R, van Lingen A, Lammertsma AA, et al
    PET/CT derived whole body and bone marrow dosimetry of 89Zr-cetuximab.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.147819.
    PubMed     Text format     Abstract available


  368. JAMES ML, Belichenko NP, Nguyen TV, Andrews LE, et al
    PET imaging of translocator protein (18kDa) in a mouse model of Alzheimer's disease using 18F-PBR06.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.141648.
    PubMed     Text format     Abstract available


  369. MARCUS C, Paidpally V, Antoniou A, Zaheer A, et al
    FDG PET/CT & Lung Cancer: Value of Fourth and Subsequent Post Therapy follow up scans in Patient Management.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.147884.
    PubMed     Text format     Abstract available


  370. LIN YC, Chen SW, Hsieh TC, Yen KY, et al
    Risk Stratification of Metastatic Neck Nodes by Computed Tomogram and Positron Emission Tomogram in Patients with Head and Neck Cancer Receiving Definitive Radiotherapy.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.148023.
    PubMed     Text format     Abstract available


  371. KRATOCHWIL C, Giesel FL, Leotta K, Eder M, et al
    PMPA for nephroprotection in PSMA-targeted radionuclide therapy of prostate cancer.
    J Nucl Med. 2015 Jan 22. pii: jnumed.114.147181.
    PubMed     Text format     Abstract available


  372. NAGANAWA M, Zheng MQ, Henry S, Nabulsi N, et al
    Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the kappa opioid receptor.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.147975.
    PubMed     Text format     Abstract available


  373. WEHRL H, Sauter A, Divine MR, Pichler BJ, et al
    Combined PET/MR: a Technology Becomes Mature.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.150318.
    PubMed     Text format     Abstract available


  374. HILLNER BE, Siegel BA, Hanna L, Duan F, et al
    18F-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.150391.
    PubMed     Text format     Abstract available


  375. APPEL L, Jonasson M, Danfors T, Nyholm D, et al
    Use of 11C-PE2I Positron Emission Tomography in Differential Diagnosis of Parkinsonian Disorders.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.148619.
    PubMed     Text format     Abstract available


  376. AIRAS L, Dickens A, Elo P, Marjamaki PM, et al
    In vivo Positron Emission Tomography Imaging Demonstrates Diminished Microglial Activation after Fingolimod Treatment in an Animal Model of Multiple Sclerosis.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.149955.
    PubMed     Text format     Abstract available


  377. FURST S, Grimm R, Hong I, Souvatzoglou M, et al
    Motion Correction Strategies for Integrated PET/MR.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.146787.
    PubMed     Text format     Abstract available


  378. CALAIS J, Thureau S, Dubray B, Modzelewski R, et al
    High 18F-FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemo-radiotherapy for non-small cell lung cancer.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.144253.
    PubMed     Text format     Abstract available


  379. USLU L, Donig J, Link M, Rosenberg J, et al
    Value of 18F-FDG PET and PET/CT for Evaluation of Pediatric Malignancies.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.146290.
    PubMed     Text format     Abstract available


  380. LI Y, Tsui W, Rusinek H, Butler T, et al
    Cortical Lamina Binding of PET Amyloid and Tau Tracers in Alzheimer's disease.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.149229.
    PubMed     Text format     Abstract available


  381. PRATO FS, Butler J, Sykes J, Keenliside L, et al
    Can The Inflammatory Response Be Evaluated Using 18F-FDG Within Zones of Microvascular Obstruction Following Myocardial Infarction?
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.147835.
    PubMed     Text format     Abstract available



  382. Nuclear medicine residency programs ranked.
    J Nucl Med. 2015;56:14N.
    PubMed     Text format    



  383. SNMMI leadership update: facilitation and collaboration to lead the future.
    J Nucl Med. 2015;56:16N.
    PubMed     Text format    



  384. Joint NCI/SNMMI workshop on targeted radionuclide therapy.
    J Nucl Med. 2015;56:13N.
    PubMed     Text format    



  385. SNMMI comments on NRC part 35 and part 20 rules.
    J Nucl Med. 2015;56:11N.
    PubMed     Text format    


  386. KUIK WJ, Kema IP, Brouwers AH, Zijlma R, et al
    In vivo biodistribution of no-carrier-added 6-18F-fluoro-3,4-dihydroxy-L-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitution.
    J Nucl Med. 2015;56:106-12.
    PubMed     Text format     Abstract available


  387. WAYUA C, Low PS
    Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancers.
    J Nucl Med. 2015;56:113-9.
    PubMed     Text format     Abstract available


    December 2014
  388. CIMITAN M, Evangelista L, Hodolic M, Mariani G, et al
    Gleason score at diagnosis predicts the detection rate of 18F-choline PET/CT performed at biochemical recurrence of prostate cancer: experience with 1,000 patients.
    J Nucl Med. 2014 Dec 31. pii: jnumed.114.141887.
    PubMed     Text format     Abstract available


  389. NENSA F, Tezgah E, Poeppel TD, Jensen CJ, et al
    Integrated 18F-FDG-PET/MRI in the assessment of cardiac masses: A pilot study.
    J Nucl Med. 2014 Dec 31. pii: jnumed.114.147744.
    PubMed     Text format     Abstract available


  390. VAN DIJK LK, Boerman OC, Franssen GM, Kaanders JH, et al
    Cetuximab-F(ab')2-SPECT and FDG-PET for prediction and response monitoring of combined modality treatment of human head and neck carcinomas in a mouse model.
    J Nucl Med. 2014 Dec 31. pii: jnumed.114.148296.
    PubMed     Text format     Abstract available


  391. OYEN WJ, de Jong IJ
    Molecular imaging of prostate cancer : tapping into the opportunities.
    J Nucl Med. 2014 Dec 31. pii: jnumed.114.150219.
    PubMed     Text format    


  392. JANSEN N, Suchorska B, Wenter V, Schmid-Tannwald C, et al
    Prognostic Significance of Dynamic 18F-FET-PET in Newly Diagnosed Astrocytic High Grade Glioma.
    J Nucl Med. 2014 Dec 23. pii: jnumed.114.144675.
    PubMed     Text format     Abstract available


  393. BONDUE B, Sherer F, Van Simaeys G, Doumont G, et al
    PET-CT with 18F-FDG and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
    J Nucl Med. 2014 Dec 23. pii: jnumed.114.147421.
    PubMed     Text format     Abstract available


  394. JHAVERI K, Linden H
    Measuring Tumor Metabolism by FDG PET predicts outcome in a multicenter study: A step-off in the right direction.
    J Nucl Med. 2014 Dec 23. pii: jnumed.114.151175.
    PubMed     Text format    


  395. PARK JW, Jung K, Lee JH, Quach CH, et al
    18F-FDG PET/CT Monitoring of beta3 Agonist-Stimulated Brown Adipocyte Recruitment in White Adipose Tissue.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.147603.
    PubMed     Text format     Abstract available


  396. KANG C, Lin C, Yang L, Ho T, et al
    Positive Clinical Impact of an Additional PET/CT Scan before Adjuvant Radiotherapy or Concurrent Chemoradiotherapy in Patients with Advanced Oral Cavity Squamous Cell Carcinoma.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.145300.
    PubMed     Text format     Abstract available


  397. PARK SY, Cho A, Yu WS, Lee CY, et al
    Prognostic value of total lesion glycolysis by18F-fluorodeoxyglucose positron emission tomography/computed tomography in surgically resected stage IA non-small cell lung cancer.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.147561.
    PubMed     Text format     Abstract available


  398. FLETCHER JW, Logan TF, Eitel JA, Mathias CJ, et al
    Whole-body PET/CT Evaluation of Tumor Perfusion using Generator-based 62Cu-ETS: Validation by Direct Comparison to 15O-Water in Metastatic Renal Cell Carcinoma.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.148106.
    PubMed     Text format     Abstract available


  399. DUNKL V, Cleff C, Stoffels G, Judov N, et al
    The usefulness of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the clinical evaluation of brain tumors in children and adolescents.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.148734.
    PubMed     Text format     Abstract available


  400. HUANG HJ, Isakow W, Byers DE, Engle JT, et al
    Imaging pulmonary iNOS expression with positron emission tomography.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.146381.
    PubMed     Text format     Abstract available


  401. SURTI S
    Update in time-of-flight PET imaging.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.145029.
    PubMed     Text format     Abstract available


  402. SUNDERLAND JJ, Christian PE
    Quantitative PET/CT scanner performance characterization based upon the Clinical Trials Network oncology clinical simulator phantom.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.148056.
    PubMed     Text format     Abstract available


  403. KREISL WC, Bhatia R, Morse CL, Woock AE, et al
    Increased P-gp inhibition at the human blood brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.146894.
    PubMed     Text format     Abstract available


  404. BURGER IA, Wurnig MC, Becker A, Kenkel D, et al
    Hybrid PET/MRI: An Algorithm to reduce Metal Artifacts from Dental Implants in Dixon-based Attenuation Map Generation using a MAVRIC sequence.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.145862.
    PubMed     Text format     Abstract available


  405. HATT M, Majdoub M, Vallieres M, Tixier F, et al
    FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.144055.
    PubMed     Text format     Abstract available


  406. HERRMANN K, Czernin J, Wolin EM, Gupta P, et al
    Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.148247.
    PubMed     Text format     Abstract available


  407. CHEN CJ, Bando K, Ashino H, Taguchi K, et al
    In Vivo SPECT Imaging of Amyloid-beta Deposition with Radioiodinated Imidazo[1,2-alpha]pyridine Derivative DRM106 in Mouse Model of Alzheimer's Disease.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.146944.
    PubMed     Text format     Abstract available


  408. SHALGUNOV V, van Wieringen JP, Janssen H, Fransen PM, et al
    Synthesis And Evaluation In Rats Of The Dopamine D2/3 Receptor Agonist 18F-AMC20 As Potential Radioligand For PET.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.145466.
    PubMed     Text format     Abstract available


  409. CONNOLLY RM, Leal JP, Goetz MP, Zhang Z, et al
    TBCRC 008: Early change in 18-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) predicts response to preoperative systemic therapy (PST) in HER2-negative primary operable breast cancer.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.144741.
    PubMed     Text format     Abstract available


  410. OOSTING SF, Brouwers AH, van Es SC, Nagengast WB, et al
    89Zr-bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Anti-angiogenic Treatment.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.144840.
    PubMed     Text format     Abstract available


  411. KIM M, Achmad A, Higuchi T, Arisaka Y, et al
    Effects of intra-tumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-FAMT PET/CT in oral squamous cell carcinoma.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.144014.
    PubMed     Text format     Abstract available


  412. VAN KRUCHTEN M, de Vries EF, Arts HJ, Jager NM, et al
    Assessment of Estrogen Receptor Expression in Epithelial Ovarian Cancer Patients using 18F-FES-PET/CT.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.147579.
    PubMed     Text format     Abstract available


  413. CERCI JJ, Fanti S, Redondo F, Gyorke T, et al
    Reply: Critical Views on the Prognostic Potential and Interpretation of Bone Marrow 18F-FDG PET in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.150086.
    PubMed     Text format    


  414. ADAMS H, Kwee TC
    Letter: Critical Views on the Prognostic Potential and Interpretation of Bone Marrow 18F-FDG PET in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.148577.
    PubMed     Text format    


  415. KIM EE
    Nuclear Medicine: A Guide for Healthcare Professionals and Patients.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.148809.
    PubMed     Text format    


  416. KIM EE
    Radiology for PET/CT Reporting.
    J Nucl Med. 2014 Dec 4. pii: jnumed.114.148692.
    PubMed     Text format    



  417. 2014 Cassen Lecture: What Have We Learned from the National Oncologic PET Registry?
    J Nucl Med. 2014;55:9N-15N.
    PubMed     Text format    


  418. KIM EE
    Clinical Applications of SPECT-CT.
    J Nucl Med. 2014;55:2078.
    PubMed     Text format    


  419. KIM EE
    PET/MRI: Methodology and Clinical Applications.
    J Nucl Med. 2014;55:2078.
    PubMed     Text format    


  420. DORAN MG, Watson PA, Cheal SM, Spratt DE, et al
    Annotating STEAP1 Regulation in Prostate Cancer with 89Zr Immuno-PET.
    J Nucl Med. 2014;55:2045-9.
    PubMed     Text format     Abstract available


  421. ROUZET F, Chequer R, Benali K, Lepage L, et al
    Respective Performance of 18F-FDG PET and Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Prosthetic Valve Endocarditis.
    J Nucl Med. 2014;55:1980-5.
    PubMed     Text format     Abstract available


  422. HILLMER AT, Wooten DW, Bajwa AK, Higgins AT, et al
    First-in-Human Evaluation of 18F-Mefway, a PET Radioligand Specific to Serotonin-1A Receptors.
    J Nucl Med. 2014;55:1973-9.
    PubMed     Text format     Abstract available


  423. FENG L, Svarer C, Thomsen G, de Nijs R, et al
    In Vivo Quantification of Cerebral Translocator Protein Binding in Humans Using 6-Chloro-2-(4'-123I-Iodophenyl)-3-(N,N-Diethyl)-Imidazo[1,2-a]Pyridine-3-Acetamid e SPECT.
    J Nucl Med. 2014;55:1966-72.
    PubMed     Text format     Abstract available


  424. O'BRIEN JT, Firbank MJ, Davison C, Barnett N, et al
    18F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias.
    J Nucl Med. 2014;55:1959-65.
    PubMed     Text format     Abstract available


  425. GRUENEISEN J, Schaarschmidt BM, Beiderwellen K, Schulze-Hagen A, et al
    Diagnostic Value of Diffusion-Weighted Imaging in Simultaneous 18F-FDG PET/MR Imaging for Whole-Body Staging of Women with Pelvic Malignancies.
    J Nucl Med. 2014;55:1930-5.
    PubMed     Text format     Abstract available


  426. KARANTANIS D, Kalkanis D, Czernin J, Herrmann K, et al
    Perceived Misinterpretation Rates in Oncologic 18F-FDG PET/CT Studies: A Survey of Referring Physicians.
    J Nucl Med. 2014;55:1925-9.
    PubMed     Text format     Abstract available


  427. SIEGEL JA, Stabin MG
    Medical imaging: the challenges of radiation risk assessment.
    J Nucl Med. 2014;55:16N-17N.
    PubMed     Text format    


  428. IWAMOTO M, Kawada K, Nakamoto Y, Itatani Y, et al
    Regulation of 18F-FDG Accumulation in Colorectal Cancer Cells with Mutated KRAS.
    J Nucl Med. 2014;55:2038-44.
    PubMed     Text format     Abstract available


  429. CORNELISSEN B, Able S, Kartsonaki C, Kersemans V, et al
    Imaging DNA Damage Allows Detection of Preneoplasia in the BALB-neuT Model of Breast Cancer.
    J Nucl Med. 2014;55:2026-31.
    PubMed     Text format     Abstract available


  430. CHENG DW, Ersahin D, Staib LH, Della Latta D, et al
    Using SUV as a guide to 18F-FDG dose reduction.
    J Nucl Med. 2014;55:1998-2002.
    PubMed     Text format     Abstract available


  431. SCHUSTER DM, Nanni C, Fanti S, Oka S, et al
    Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.
    J Nucl Med. 2014;55:1986-92.
    PubMed     Text format     Abstract available


  432. HICKS RJ
    The customer is always right, even when you are justifiably wrong.
    J Nucl Med. 2014;55:1923-4.
    PubMed     Text format    


  433. JAGER NA, Westra J, Golestani R, van Dam GM, et al
    Folate receptor-beta imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaque.
    J Nucl Med. 2014;55:1945-51.
    PubMed     Text format     Abstract available


    November 2014
  434. MURTHY VL, Lee BC, Sitek A, Naya M, et al
    Comparison and Prognostic Validation of Multiple Methods of Quantification of Myocardial Blood Flow with 82Rb PET.
    J Nucl Med. 2014 Nov 26. pii: jnumed.114.145342.
    PubMed     Text format     Abstract available


  435. CARR R, Fanti S, Paez D, Cerci JJ, et al
    Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2014 Nov 26. pii: jnumed.114.145326.
    PubMed     Text format     Abstract available


  436. PRESTWICH R, Sen M, Scarsbrook A
    Letter: Qualitative 18F-FDG PET/CT Response Evaluation After Chemotherapy or Radiotherapy for Head and Neck Squamous Cell Carcinoma: Is There an Equivocal Group?
    J Nucl Med. 2014 Nov 26. pii: jnumed.114.148114.
    PubMed     Text format    


  437. SUBRAMANIAM RM
    Reply: Qualitative 18F-FDG PET/CT Response Evaluation After Chemotherapy or Radiotherapy for Head and Neck Squamous Cell Carcinoma: Is There an Equivocal Group?
    J Nucl Med. 2014 Nov 26. pii: jnumed.114.148379.
    PubMed     Text format    


  438. CHATALIC KL, Franssen GM, van Weerden WM, McBride WJ, et al
    Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer.
    J Nucl Med. 2014 Nov 20. pii: jnumed.114.141143.
    PubMed     Text format     Abstract available


  439. CAOBELLI F, Ren Kaiser S, Thackeray JT, Bengel FM, et al
    IQ SPECT Allows a Significant Reduction in Administered Dose and Acquisition Time for Myocardial Perfusion Imaging: Evidence from a Phantom Study.
    J Nucl Med. 2014 Nov 20. pii: jnumed.114.143560.
    PubMed     Text format     Abstract available


  440. BOILEAU I, Bloomfield PM, Rusjan PM, Mizrahi R, et al
    Whole-Body Radiation Dosimetry of 11C-Carbonyl-URB694: A PET Tracer for Fatty Acid Amide Hydrolase.
    J Nucl Med. 2014 Nov 20. pii: jnumed.114.146464.
    PubMed     Text format     Abstract available


  441. ROY S, Wang WT, Carass A, Prince JL, et al
    PET Attenuation Correction Using Synthetic CT from Ultrashort Echo-Time MR Imaging.
    J Nucl Med. 2014 Nov 20. pii: jnumed.114.143958.
    PubMed     Text format     Abstract available



  442. SNMMI Leadership Update: The Importance of Quality, Evidence, and Value in Nuclear Medicine.
    J Nucl Med. 2014;55:26N.
    PubMed     Text format    


  443. KIM EE
    Whole-Body FDG PET Imaging in Oncology: Clinical Reports.
    J Nucl Med. 2014;55:1915.
    PubMed     Text format    


  444. MAHMOOD U
    2014 SNMMI highlights lecture: Oncology.
    J Nucl Med. 2014;55:9N-24N.
    PubMed     Text format    


  445. SEGALL G
    Enhancing the value of MOC.
    J Nucl Med. 2014;55:25N.
    PubMed     Text format    


  446. TERRY SY, Abiraj K, Lok J, Gerrits D, et al
    Can 111In-RGD2 monitor response to therapy in head and neck tumor xenografts?
    J Nucl Med. 2014;55:1849-55.
    PubMed     Text format     Abstract available


  447. ZHOU X, Chen R, Xie W, Ni Y, et al
    Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas.
    J Nucl Med. 2014;55:1766-71.
    PubMed     Text format     Abstract available


  448. INOUE K, Gibbs SL, Liu F, Lee JH, et al
    Microscopic validation of macroscopic in vivo images enabled by same-slide optical and nuclear fusion.
    J Nucl Med. 2014;55:1899-904.
    PubMed     Text format     Abstract available


  449. GJERLOFF T, Jakobsen S, Nahimi A, Munk OL, et al
    In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic analyses.
    J Nucl Med. 2014;55:1818-24.
    PubMed     Text format     Abstract available


  450. KRULL KR, Minoshima S, Edelmann M, Morris B, et al
    Regional brain glucose metabolism and neurocognitive function in adult survivors of childhood cancer treated with cranial radiation.
    J Nucl Med. 2014;55:1805-10.
    PubMed     Text format     Abstract available


  451. HEISS WD
    Radionuclide imaging in ischemic stroke.
    J Nucl Med. 2014;55:1831-41.
    PubMed     Text format     Abstract available


  452. DE PROST N, Feng Y, Wellman T, Tucci MR, et al
    18F-FDG kinetics parameters depend on the mechanism of injury in early experimental acute respiratory distress syndrome.
    J Nucl Med. 2014;55:1871-7.
    PubMed     Text format     Abstract available


  453. SATTLER B, Kranz M, Starke A, Wilke S, et al
    Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.
    J Nucl Med. 2014;55:1885-92.
    PubMed     Text format     Abstract available


  454. BODEI L, Kidd M, Baum RP, Modlin IM, et al
    PRRT: Defining the paradigm shift to achieve standardization and individualization.
    J Nucl Med. 2014;55:1753-6.
    PubMed     Text format     Abstract available


  455. BASU S, Ostwal V, Ranade R, Panda D, et al
    Supportive measures and finer practice points in 177Lu-DOTATATE PRRT for NET: aiming for optimal disease management.
    J Nucl Med. 2014;55:1916-7.
    PubMed     Text format    


    October 2014
  456. SHAM JG, Kievit FM, Grierson JR, Chiarelli PA, et al
    Glypican-3-Targeting F(ab')2 for 89Zr PET of Hepatocellular Carcinoma.
    J Nucl Med. 2014 Oct 30. pii: jnumed.114.145102.
    PubMed     Text format     Abstract available


  457. LIN LT, Chang CH, Yu HL, Liu RS, et al
    Evaluation of the Therapeutic and Diagnostic Effects of PEGylated Liposome-Embedded 188Re on Human Non-Small Cell Lung Cancer Using an Orthotopic Small-Animal Model.
    J Nucl Med. 2014 Oct 27. pii: jnumed.114.140418.
    PubMed     Text format     Abstract available


  458. SCHILLACI O
    Can PET/CT Guide the Personalized Treatment of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms?
    J Nucl Med. 2014 Oct 23. pii: jnumed.114.147538.
    PubMed     Text format    


  459. VALLABHAJOSULA S, Nikolopoulou A, Babich JW, Osborne JR, et al
    99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer.
    J Nucl Med. 2014 Oct 23. pii: jnumed.114.140426.
    PubMed     Text format     Abstract available


  460. JENTZEN W, Hoppenbrouwers J, van Leeuwen P, van der Velden D, et al
    Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET Imaging.
    J Nucl Med. 2014 Oct 20. pii: jnumed.114.144089.
    PubMed     Text format     Abstract available


  461. VERWER EE, Bahce I, van Velden FH, Yaqub M, et al
    Parametric Methods for Quantification of 18F-FAZA Kinetics in Non-Small Cell Lung Cancer Patients.
    J Nucl Med. 2014 Oct 16. pii: jnumed.114.141846.
    PubMed     Text format     Abstract available


  462. SIMSEK DH, Kuyumcu S, Turkmen C, Sanli Y, et al
    Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?
    J Nucl Med. 2014 Oct 14. pii: jnumed.114.142224.
    PubMed     Text format     Abstract available


  463. PAUL S, Khanapur S, Elsinga PH, Ishiwata K, et al
    PET Imaging of Adenosine A1 Receptor Occupancy.
    J Nucl Med. 2014 Oct 9. pii: jnumed.114.147736.
    PubMed     Text format    


  464. BAHRI H, Laurence L, Edeline J, Leghzali H, et al
    High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation.
    J Nucl Med. 2014 Oct 6. pii: jnumed.114.144386.
    PubMed     Text format     Abstract available


  465. IZQUIERDO-GARCIA D, Hansen AE, Forster S, Benoit D, et al
    An SPM8-Based Approach for Attenuation Correction Combining Segmentation and Nonrigid Template Formation: Application to Simultaneous PET/MR Brain Imaging.
    J Nucl Med. 2014 Oct 2. pii: jnumed.113.136341.
    PubMed     Text format     Abstract available


  466. RYLOVA SN, Barnucz E, Barnucz E, Fani M, et al
    Does Imaging alphavbeta3 Integrin Expression with PET Detect Changes in Angiogenesis During Bevacizumab Therapy?
    J Nucl Med. 2014 Oct 2. pii: jnumed.114.137570.
    PubMed     Text format     Abstract available


  467. MANSI L, Cuccurullo V
    Diagnostic imaging in neuroendocrine tumors.
    J Nucl Med. 2014;55:1576-7.
    PubMed     Text format    


  468. MORGAT C, Mishra AK, Varshney R, Allard M, et al
    Targeting neuropeptide receptors for cancer imaging and therapy: perspectives with bombesin, neurotensin, and neuropeptide-Y receptors.
    J Nucl Med. 2014;55:1650-7.
    PubMed     Text format     Abstract available


  469. BROISAT A, Toczek J, Dumas LS, Ahmadi M, et al
    99mTc-cAbVCAM1-5 imaging is a sensitive and reproducible tool for the detection of inflamed atherosclerotic lesions in mice.
    J Nucl Med. 2014;55:1678-84.
    PubMed     Text format     Abstract available


  470. SUZUKI C, Tsuji AB, Kato K, Kikuchi T, et al
    Preclinical characterization of 5-amino-4-oxo-[6-11C]hexanoic acid as an imaging probe to estimate protoporphyrin IX accumulation induced by exogenous aminolevulinic acid.
    J Nucl Med. 2014;55:1671-7.
    PubMed     Text format     Abstract available


  471. BARRET O, Hannestad J, Alagille D, Vala C, et al
    Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys.
    J Nucl Med. 2014;55:1712-8.
    PubMed     Text format     Abstract available


  472. DEMEURE F, Hanin FX, Bol A, Vincent MF, et al
    A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging.
    J Nucl Med. 2014;55:1629-35.
    PubMed     Text format     Abstract available


  473. BRUST P, Deuther-Conrad W, Becker G, Patt M, et al
    Distinctive in vivo kinetics of the new sigma1 receptor ligands (R)-(+)- and (S)-(-)-18F-fluspidine in porcine brain.
    J Nucl Med. 2014;55:1730-6.
    PubMed     Text format     Abstract available


  474. MULLER C, Bunka M, Haller S, Koster U, et al
    Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice.
    J Nucl Med. 2014;55:1658-64.
    PubMed     Text format     Abstract available


    September 2014
  475. BURGER IA, Zitzmann-Kolbe S, Pruim J, Friebe M, et al
    First Clinical Results of (d)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma.
    J Nucl Med. 2014 Sep 25. pii: jnumed.114.140699.
    PubMed     Text format     Abstract available


  476. BEAINO W, Anderson CJ
    PET Imaging of Very Late Antigen-4 in Melanoma: Comparison of 68Ga- and 64Cu-Labeled NODAGA and CB-TE1A1P-LLP2A Conjugates.
    J Nucl Med. 2014 Sep 25. pii: jnumed.114.144881.
    PubMed     Text format     Abstract available


  477. LIU C, Sinusas AJ
    Is Assessment of Absolute Myocardial Perfusion with SPECT Ready for Prime Time?
    J Nucl Med. 2014 Sep 18. pii: jnumed.114.144550.
    PubMed     Text format    


  478. VAN DIJK LK, Boerman OC, Franssen GM, Lok J, et al
    Early Response Monitoring with 18F-FDG PET and Cetuximab-F(ab')2-SPECT After Radiotherapy of Human Head And Neck Squamous Cell Carcinomas in a Mouse Model.
    J Nucl Med. 2014 Sep 18. pii: jnumed.114.141762.
    PubMed     Text format     Abstract available


  479. CERCI JJ, Gyorke T, Fanti S, Paez D, et al
    Combined PET and Biopsy Evidence of Marrow Involvement Improves Prognostic Prediction in Diffuse Large B-Cell Lymphoma.
    J Nucl Med. 2014 Sep 11. pii: jnumed.113.134486.
    PubMed     Text format     Abstract available


  480. RIEDL CC, Slobod E, Jochelson M, Morrow M, et al
    Retrospective Analysis of 18F-FDG PET/CT for Staging Asymptomatic Breast Cancer Patients Younger Than 40 Years.
    J Nucl Med. 2014 Sep 11. pii: jnumed.114.143297.
    PubMed     Text format     Abstract available


  481. HUANG W, Fan M, Liu B, Fu Z, et al
    Value of Metabolic Tumor Volume on Repeated 18F-FDG PET/CT for Early Prediction of Survival in Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.
    J Nucl Med. 2014 Sep 11. pii: jnumed.114.142919.
    PubMed     Text format     Abstract available


  482. WELLS RG, Timmins R, Klein R, Lockwood J, et al
    Dynamic SPECT Measurement of Absolute Myocardial Blood Flow in a Porcine Model.
    J Nucl Med. 2014 Sep 4. pii: jnumed.114.139782.
    PubMed     Text format     Abstract available


  483. KAMSON DO, Lee TJ, Varadarajan K, Robinette NL, et al
    Clinical Significance of Tryptophan Metabolism in the Nontumoral Hemisphere in Patients with Malignant Glioma.
    J Nucl Med. 2014 Sep 4. pii: jnumed.114.141002.
    PubMed     Text format     Abstract available



  484. A new focus on women in nuclear medicine.
    J Nucl Med. 2014;55:15N.
    PubMed     Text format    


  485. SHAH M, Seibyl J, Cartier A, Bhatt R, et al
    Molecular imaging insights into neurodegeneration: focus on alpha-synuclein radiotracers.
    J Nucl Med. 2014;55:1397-400.
    PubMed     Text format     Abstract available


  486. KIM YI, Phi JH, Paeng JC, Choi H, et al
    In vivo evaluation of angiogenic activity and its correlation with efficacy of indirect revascularization surgery in pediatric moyamoya disease.
    J Nucl Med. 2014;55:1467-72.
    PubMed     Text format     Abstract available


  487. GRAHAM MM
    Ventilation-perfusion lung scanning: stuck in a rut?
    J Nucl Med. 2014;55:1395-6.
    PubMed     Text format    


  488. XIE T, Zaidi H
    Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes.
    J Nucl Med. 2014;55:1459-66.
    PubMed     Text format     Abstract available


  489. WITNEY TH, Pisaneschi F, Alam IS, Trousil S, et al
    Preclinical evaluation of 3-18F-fluoro-2,2-dimethylpropionic acid as an imaging agent for tumor detection.
    J Nucl Med. 2014;55:1506-12.
    PubMed     Text format     Abstract available


  490. WILKS MQ, Knowles SM, Wu AM, Huang SC, et al
    Improved modeling of in vivo kinetics of slowly diffusing radiotracers for tumor imaging.
    J Nucl Med. 2014;55:1539-44.
    PubMed     Text format     Abstract available


  491. LIU Z, Pourghiasian M, Benard F, Pan J, et al
    Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging.
    J Nucl Med. 2014;55:1499-505.
    PubMed     Text format     Abstract available


    August 2014
  492. ETCHEBEHERE EC, de Oliveira Santos A, Gumz B, Vicente A, et al
    68Ga-DOTATATE PET/CT, 99mTc-HYNIC-Octreotide SPECT/CT, and Whole-Body MR Imaging in Detection of Neuroendocrine Tumors: A Prospective Trial.
    J Nucl Med. 2014 Aug 28. pii: jnumed.114.144543.
    PubMed     Text format     Abstract available


  493. PREVRHAL S, Heinzer S, Wulker C, Renisch S, et al
    Fat-Constrained 18F-FDG PET Reconstruction in Hybrid PET/MR Imaging.
    J Nucl Med. 2014 Aug 28. pii: jnumed.114.139758.
    PubMed     Text format     Abstract available


  494. MACHULLA HJ, Malik N
    Fatty Acids as a Concept for Probes in Cardiologic PET/MR Imaging.
    J Nucl Med. 2014 Aug 25. pii: jnumed.114.146142.
    PubMed     Text format    


  495. GOURNI E, Mansi R, Jamous M, Waser B, et al
    N-Terminal Modifications Improve the Receptor Affinity and Pharmacokinetics of Radiolabeled Peptidic Gastrin-Releasing Peptide Receptor Antagonists: Examples of 68Ga- and 64Cu-Labeled Peptides for PET Imaging.
    J Nucl Med. 2014 Aug 21. pii: jnumed.114.141242.
    PubMed     Text format     Abstract available


  496. THURFJELL L, Lilja J, Lundqvist R, Buckley C, et al
    Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads.
    J Nucl Med. 2014 Aug 21. pii: jnumed.114.142109.
    PubMed     Text format     Abstract available


  497. CHOI H, Cheon GJ, Kim HJ, Choi SH, et al
    Segmentation-Based MR Attenuation Correction Including Bones Also Affects Quantitation in Brain Study: An Initial Result of 18F-FP-CIT PET/MR for Patients with Parkinsonism.
    J Nucl Med. 2014 Aug 11. pii: jnumed.114.138636.
    PubMed     Text format     Abstract available


  498. LEE SH, Oh BM, Lee G, Choi H, et al
    Feasibility of 18F-FDG PET as a Noninvasive Diagnostic Tool of Muscle Denervation: A Preliminary Study.
    J Nucl Med. 2014 Aug 7. pii: jnumed.114.140731.
    PubMed     Text format     Abstract available


    May 2014
  499. PERISINAKIS K, Seimenis I, Tzedakis A, Damilakis J, et al
    Perfusion Scintigraphy Versus 256-Slice CT Angiography in Pregnant Patients Suspected of Pulmonary Embolism: Comparison of Radiation Risks.
    J Nucl Med. 2014 May 29. pii: jnumed.114.137968.
    PubMed     Text format     Abstract available


  500. VAN GOOL MH, Aukema TS, Schaake EE, Rijna H, et al
    Timing of Metabolic Response Monitoring During Erlotinib Treatment in Non-Small Cell Lung Cancer.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


    April 2014
  501. LUTJE S, Rijpkema M, Franssen GM, Fracasso G, et al
    Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: